{"meta":{"query_hash":"946f6b568667","filters":{"venue":"The Lancet Rheumatology"},"cohort_total":90,"direct_labels_cover":0,"predictions_cover":90,"exported":90,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/946f6b568667","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Lancet+Rheumatology"},"results":[{"id":"W2965661216","doi":"10.1016/s2665-9913(19)30016-5","title":"Treating to target or treating the patient in rheumatoid arthritis?","year":2019,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Western University","funders":"Merck; Union Chimique Belge; AbbVie; Biogen; Gilead UK and Ireland Corporate Contributions; Roche","keywords":"Rheumatoid arthritis; Medicine; Dermatology; Intensive care medicine; Immunology","score_opus":0.01823564599991981,"score_gpt":0.2837151195596671,"score_spread":0.2654794735597473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965661216","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033468954,0.16953808,0.00030004655,0.7694525,0.0477954,0.000013790733,0.000059012273,0.000034100896,0.0124724535],"genre_scores_gemma":[0.012386473,0.24781288,0.0015228067,0.6080085,0.11886224,0.00007376327,0.000100471996,0.000071080125,0.011161767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902345,0.0046653287,0.00091934664,0.00068229996,0.0025342298,0.00096440467],"domain_scores_gemma":[0.9788088,0.011085127,0.0018077826,0.00084298267,0.0028021443,0.004653149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0115664005,0.00080390397,0.0021521265,0.0013278788,0.0022088806,0.00543992,0.0015244437,0.01097288,0.01724669],"category_scores_gemma":[0.036499027,0.00054303964,0.0013337409,0.0011527104,0.007336597,0.009032572,0.00340194,0.022365151,0.0068776063],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001770748,0.00016087257,0.0008781184,0.002027267,0.00012890712,0.00025098494,0.00055736705,0.00007471858,0.00025304925,0.03062275,0.81048584,0.15438302],"study_design_scores_gemma":[0.00032699117,0.00022610262,0.0019627856,0.0075184987,0.00016096505,0.0012990745,0.0014813446,0.0000960065,0.000109502944,0.034251172,0.9524922,0.00007539562],"about_ca_topic_score_codex":0.003990032,"about_ca_topic_score_gemma":0.01203391,"teacher_disagreement_score":0.01724669,"about_ca_system_score_codex":0.0027140765,"about_ca_system_score_gemma":0.009996285,"threshold_uncertainty_score":0.061169684},"labels":[],"label_agreement":null},{"id":"W2968610608","doi":"10.1016/s2665-9913(19)30005-0","title":"Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Clinical Research Institute; Mount Sinai Hospital; Western University","funders":"Merck Sharp and Dohme; Pfizer","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Methotrexate; Janus kinase inhibitor; Placebo; Internal medicine; Clinical endpoint; Erythrocyte sedimentation rate; Phases of clinical research; Clinical trial; Gastroenterology; Surgery; Pharmacology","score_opus":0.01463993603832017,"score_gpt":0.28589682534157734,"score_spread":0.2712568893032572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968610608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865935,0.007189982,0.00055472413,0.00082582026,0.00057448033,0.001203145,0.0006694805,0.00014349057,0.0022452788],"genre_scores_gemma":[0.9900344,0.0024005498,0.0007558533,0.0011061544,0.00054561667,0.0011077367,0.00089806895,0.0000255037,0.0031261663],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994093,0.00027773544,0.000038466696,0.000102514095,0.00004289723,0.00012908029],"domain_scores_gemma":[0.99925333,0.00024953458,0.00015526319,0.00007320284,0.00003220478,0.00023648408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014024369,0.0020120917,0.0031467255,0.00036768892,0.0004577678,0.001128939,0.0007425878,0.0018197118,0.0070437565],"category_scores_gemma":[0.0014412461,0.00058162777,0.0027078278,0.00035540995,0.0012011422,0.001123754,0.00040701573,0.0032661885,0.001387051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97392976,0.0021120233,0.0006218552,0.0005240705,0.0010072719,0.000082136605,0.00006393311,0.00029240758,0.0031034031,0.00008235717,0.00077358476,0.017407168],"study_design_scores_gemma":[0.9593119,0.037362836,0.0019056824,0.000027344815,0.0003162369,0.000056881694,0.000018442495,0.00019005424,0.00020408133,0.00014939083,0.0004435903,0.000013543482],"about_ca_topic_score_codex":0.0008082642,"about_ca_topic_score_gemma":0.0017165738,"teacher_disagreement_score":0.0070437565,"about_ca_system_score_codex":0.0007068163,"about_ca_system_score_gemma":0.0006302188,"threshold_uncertainty_score":0.023563683},"labels":[],"label_agreement":null},{"id":"W2981952270","doi":"10.1016/s2665-9913(19)30071-2","title":"How low can we go for continued dosing of rituximab in rheumatoid arthritis?","year":2019,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Rituximab; Rheumatoid arthritis; Medicine; Internal medicine; Scopus; Rheumatology; Dosing; Physical therapy; MEDLINE; Lymphoma; Political science","score_opus":0.017998213026969464,"score_gpt":0.2721245370797979,"score_spread":0.2541263240528284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981952270","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032580264,0.15692085,0.0024218247,0.817564,0.009822281,0.000036832498,0.000291396,0.0003563036,0.009328489],"genre_scores_gemma":[0.11329454,0.1008432,0.012574948,0.72580135,0.040411044,0.00033694855,0.00051867036,0.0007053601,0.0055139875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9731522,0.011075121,0.0043748305,0.0015633878,0.008225195,0.0016093627],"domain_scores_gemma":[0.8818702,0.07012391,0.016172623,0.002492981,0.019285588,0.010054699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02709389,0.0015084888,0.0058380063,0.0019502224,0.0024753213,0.011115281,0.0037813273,0.012998332,0.012207224],"category_scores_gemma":[0.17044021,0.0008271545,0.0031573663,0.0013578527,0.0048547396,0.014254075,0.0031803076,0.030761598,0.010154832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044533196,0.0009570572,0.009164187,0.005351192,0.0024048658,0.00081972685,0.0009174869,0.0017556737,0.0024336628,0.02080994,0.41090178,0.54003114],"study_design_scores_gemma":[0.0034236882,0.0032029606,0.03189085,0.03324428,0.0053597796,0.002636022,0.002262639,0.0030561697,0.0020912057,0.11412027,0.79802215,0.00068990537],"about_ca_topic_score_codex":0.009849991,"about_ca_topic_score_gemma":0.0119137755,"teacher_disagreement_score":0.02709389,"about_ca_system_score_codex":0.0082379915,"about_ca_system_score_gemma":0.012266063,"threshold_uncertainty_score":0.1432879},"labels":[],"label_agreement":null},{"id":"W2982276699","doi":"10.1016/s2665-9913(19)30069-4","title":"Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma","year":2019,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Context (archaeology); Heart block; Pregnancy; Heart disease; Gestation; Pediatrics; Block (permutation group theory); Fetus; Internal medicine; Electrocardiography","score_opus":0.02582527995446096,"score_gpt":0.30972484033807646,"score_spread":0.2838995603836155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982276699","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051801294,0.12702395,0.009911464,0.78312546,0.016947197,0.00006076106,0.0004183754,0.00036246225,0.010349052],"genre_scores_gemma":[0.48561874,0.08900214,0.022167126,0.29597443,0.10346876,0.000095439354,0.0003983423,0.00018637087,0.0030886824],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944793,0.001962704,0.00095608394,0.00071523874,0.0015962841,0.00029036496],"domain_scores_gemma":[0.93094873,0.04387612,0.004829507,0.0052770884,0.0113095585,0.0037590254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014535695,0.0006978116,0.0019679281,0.0011579964,0.0007487205,0.0024962563,0.002810629,0.010441351,0.0011625804],"category_scores_gemma":[0.05333085,0.0004310439,0.00081168563,0.0006866555,0.005163269,0.005008022,0.0008008105,0.014641253,0.0012442262],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001648575,0.00075914,0.18591537,0.0023115962,0.0007908255,0.017421171,0.0028404035,0.0011568599,0.01625893,0.022321044,0.23182441,0.51675165],"study_design_scores_gemma":[0.0009523124,0.0036527284,0.22444355,0.015448655,0.0012733295,0.07338369,0.0117897745,0.0058928523,0.006763744,0.13460177,0.5210249,0.0007726166],"about_ca_topic_score_codex":0.0023776668,"about_ca_topic_score_gemma":0.0025995863,"teacher_disagreement_score":0.014535695,"about_ca_system_score_codex":0.0010714164,"about_ca_system_score_gemma":0.0019466867,"threshold_uncertainty_score":0.076873004},"labels":[],"label_agreement":null},{"id":"W2991307736","doi":"10.1016/s2665-9913(19)30094-3","title":"Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Rheumatoid arthritis; Sulfasalazine; Hydroxychloroquine; Internal medicine; Immunogenicity; Rheumatoid factor; Methotrexate; Immunology; Immune system; Disease","score_opus":0.028056255950839083,"score_gpt":0.30678666702331653,"score_spread":0.2787304110724774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991307736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046665,0.0040623746,0.0007453044,0.00033717908,0.00095777406,0.001812142,0.0005538331,0.000074844735,0.0009897634],"genre_scores_gemma":[0.9927488,0.0013208465,0.0009925722,0.00045572224,0.0007084334,0.001840948,0.00048020083,0.000018609875,0.0014338138],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973048,0.0015051032,0.0002524963,0.00048402257,0.00018442413,0.00026913255],"domain_scores_gemma":[0.996436,0.0015743796,0.00070928375,0.0004261004,0.00023597547,0.00061821536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004302194,0.0025268858,0.0061617866,0.000670601,0.00065700244,0.001802975,0.0018677881,0.004244611,0.0067550284],"category_scores_gemma":[0.0052095284,0.0014403756,0.0036432561,0.00060108013,0.0025984196,0.002012195,0.0007550644,0.0040655015,0.0013762651],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9963329,0.0011956152,0.00010569868,0.00016338927,0.00033561897,0.00000816831,0.000012670295,0.00006521043,0.00052820396,0.000017222023,0.000050109695,0.0011850698],"study_design_scores_gemma":[0.94593656,0.052138314,0.00071557803,0.000019989877,0.00051912357,0.000015672766,0.000012909254,0.00023853431,0.00021030473,0.00007789227,0.00010137959,0.000013704032],"about_ca_topic_score_codex":0.000977505,"about_ca_topic_score_gemma":0.0008245906,"teacher_disagreement_score":0.0067550284,"about_ca_system_score_codex":0.00122666,"about_ca_system_score_gemma":0.0010308056,"threshold_uncertainty_score":0.022752404},"labels":[],"label_agreement":null},{"id":"W3003624336","doi":"10.1016/s2665-9913(20)30009-6","title":"Psoriatic arthritis in developing and resource-poor countries","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Psoriatic arthritis; Medicine; Rheumatism; Psoriasis; Arthritis; League; Family medicine; Dermatology; Internal medicine","score_opus":0.02793665811946562,"score_gpt":0.26950194135807964,"score_spread":0.24156528323861404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003624336","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59234077,0.31943315,0.0004490619,0.049786203,0.0010902716,0.0002478286,0.018076796,0.000037821905,0.018538155],"genre_scores_gemma":[0.90748394,0.083061814,0.00036372658,0.0059634433,0.00046712393,0.00018866656,0.0015945659,0.000010161257,0.00086662435],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519354,0.002827951,0.000494169,0.00019540597,0.0004098607,0.00087910687],"domain_scores_gemma":[0.9943124,0.00168962,0.002030188,0.0002380023,0.00067454664,0.001055206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033160974,0.0006201793,0.0012949507,0.0016535178,0.001317161,0.0030292242,0.0004618466,0.001553571,0.0035782552],"category_scores_gemma":[0.0101122055,0.0005988634,0.0006501225,0.007967628,0.0014742244,0.0021210648,0.0024004153,0.0017368129,0.00039675614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00453326,0.0006763243,0.81000376,0.013803397,0.003464691,0.0019207172,0.0065678125,0.0009883328,0.0010267136,0.005268578,0.03414315,0.11760327],"study_design_scores_gemma":[0.00053483754,0.0006178238,0.96283305,0.0039126547,0.0009658226,0.0006582888,0.009418694,0.00013608065,0.00013630469,0.0019832037,0.018747194,0.000055981975],"about_ca_topic_score_codex":0.084832326,"about_ca_topic_score_gemma":0.1078973,"teacher_disagreement_score":0.084832326,"about_ca_system_score_codex":0.0023131862,"about_ca_system_score_gemma":0.0061988123,"threshold_uncertainty_score":0.16867709},"labels":[],"label_agreement":null},{"id":"W3007142604","doi":"10.1016/s2665-9913(19)30164-x","title":"Digital ulcers: should debridement be a standard of care in systemic sclerosis?","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Boehringer Ingelheim; Servier; Sanofi; Roche Products; GlaxoSmithKline","keywords":"Debridement (dental); Medicine; Wound care; Complication; Surgery; Standard of care; Wound healing; Skin ulcer; Intensive care medicine","score_opus":0.066178063511859,"score_gpt":0.28836871248999646,"score_spread":0.22219064897813745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007142604","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039301645,0.13428275,0.0021452412,0.83398366,0.018696355,0.00003681127,0.00012291716,0.000120593206,0.0066814735],"genre_scores_gemma":[0.14452033,0.2373921,0.016549455,0.48225406,0.11305328,0.00031395338,0.0004380752,0.00023119751,0.0052475235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893945,0.003062739,0.0020531514,0.0010871455,0.0035487844,0.0008537376],"domain_scores_gemma":[0.9540613,0.017237322,0.0049429107,0.0023726975,0.015499778,0.005885906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019320242,0.0008823705,0.0047229663,0.0013183992,0.0023371174,0.0071434276,0.0031166405,0.01438439,0.007512486],"category_scores_gemma":[0.055061605,0.0005990766,0.0020831393,0.001411781,0.005994198,0.009007765,0.0022849143,0.026824446,0.0031506917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003182923,0.0010444747,0.006471112,0.005517794,0.0006728689,0.001048707,0.0006420904,0.0007670135,0.00178958,0.025756335,0.3308734,0.6222336],"study_design_scores_gemma":[0.0046580853,0.0032142827,0.051990263,0.05537575,0.0019449686,0.0062142373,0.007263056,0.0035031275,0.0018682801,0.16055027,0.7026112,0.00080643967],"about_ca_topic_score_codex":0.0047254683,"about_ca_topic_score_gemma":0.009468033,"teacher_disagreement_score":0.019320242,"about_ca_system_score_codex":0.003217455,"about_ca_system_score_gemma":0.008013734,"threshold_uncertainty_score":0.10217637},"labels":[],"label_agreement":null},{"id":"W3007729962","doi":"10.1016/s2665-9913(20)30010-2","title":"The future of treatment in systemic sclerosis: can we design better trials?","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Clinical trial; Internal medicine; Immunology","score_opus":0.10330887712867001,"score_gpt":0.2947290214350071,"score_spread":0.1914201443063371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007729962","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003007662,0.6970217,0.005906219,0.26526284,0.022904607,0.0013240719,0.0006872595,0.00017500241,0.003710676],"genre_scores_gemma":[0.07495335,0.43060988,0.045035142,0.38291347,0.05604432,0.0065060644,0.001316715,0.00032930294,0.0022917436],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8284207,0.14081211,0.013725402,0.004879308,0.009144621,0.0030177564],"domain_scores_gemma":[0.6033953,0.33184534,0.027415339,0.011659841,0.017847676,0.007836564],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22235394,0.002800509,0.025556995,0.0030233962,0.0019906955,0.013942063,0.006176624,0.019003008,0.013080397],"category_scores_gemma":[0.2804496,0.0018115151,0.011245563,0.0030757776,0.008743413,0.025150236,0.004005748,0.023633419,0.0027669535],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046890646,0.0029420725,0.008316445,0.1130657,0.025591385,0.00052200234,0.0014757372,0.0084528215,0.0021838516,0.08570003,0.13977367,0.5650857],"study_design_scores_gemma":[0.08918522,0.016399996,0.012808859,0.11604226,0.026534304,0.0006024721,0.0021136543,0.007839406,0.0010458634,0.2751782,0.45111987,0.0011299672],"about_ca_topic_score_codex":0.0047127763,"about_ca_topic_score_gemma":0.007881541,"teacher_disagreement_score":0.77764606,"about_ca_system_score_codex":0.007503483,"about_ca_system_score_gemma":0.023680309,"threshold_uncertainty_score":0.95897603},"labels":[],"label_agreement":null},{"id":"W3013759133","doi":"10.1016/s2665-9913(20)30036-9","title":"Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Novartis Pharma; National Institute for Health and Care Research","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Psoriasis Area and Severity Index; Placebo; Internal medicine; Rheumatology; Psoriasis; Clinical trial; Adverse effect; Dermatology; Arthritis; Alternative medicine; Pathology","score_opus":0.01631866117627093,"score_gpt":0.27290933670092826,"score_spread":0.2565906755246573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013759133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878855,0.007843263,0.00030021142,0.00035769132,0.00011212093,0.00025751084,0.0012702992,0.00003248257,0.0010378405],"genre_scores_gemma":[0.992634,0.0022821142,0.00050478126,0.000812671,0.00025052574,0.00035988342,0.0022596344,0.000015640699,0.0008807463],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983156,0.0009483837,0.000095531206,0.00016284597,0.00019868741,0.0002789166],"domain_scores_gemma":[0.99734783,0.0007878515,0.00080400903,0.00022465075,0.00021518562,0.0006205084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057526925,0.001562606,0.0030008415,0.00033567482,0.0006068644,0.0014337698,0.0007317669,0.0018539337,0.0015824444],"category_scores_gemma":[0.0024920793,0.00047020253,0.0043810783,0.00036181815,0.0008499168,0.0014737282,0.00056167494,0.002758248,0.0004590284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8887184,0.008055269,0.04099998,0.0009727686,0.008779582,0.00029082395,0.00025402018,0.0013201123,0.0055307955,0.00016972156,0.001835813,0.04307263],"study_design_scores_gemma":[0.4239228,0.28920308,0.26471207,0.00028601728,0.01252411,0.00061866996,0.00026939102,0.0014604747,0.0027376553,0.0006138519,0.003522869,0.00012895314],"about_ca_topic_score_codex":0.0007355711,"about_ca_topic_score_gemma":0.0015141251,"teacher_disagreement_score":0.0057526925,"about_ca_system_score_codex":0.00070926646,"about_ca_system_score_gemma":0.0007666255,"threshold_uncertainty_score":0.030423522},"labels":[],"label_agreement":null},{"id":"W3016350662","doi":"10.1016/s2665-9913(20)30095-3","title":"Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"Cilag; UCB Pharma; UCLH Biomedical Research Centre; Manchester Biomedical Research Centre; Pfizer UK; University of California, San Francisco; Medac; National Institutes of Health; Mylan; McMaster University; University of Otago; University College London Hospitals NHS Foundation Trust; University of Washington; University College London; AbbVie; Rheumatology Research Foundation; Novartis; Celgene; Pfizer; Biogen; National Institute for Health and Care Research; Massachusetts General Hospital; Childhood Arthritis and Rheumatology Research Alliance; Meso Scale Diagnostics; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; Celltrion; Roche; Samsung; Bristol-Myers Squibb; Pfizer Australia; AstraZeneca; Eli Lilly and Company","keywords":"Coronavirus disease 2019 (COVID-19); Rheumatology; Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Alliance; Pandemic; Internal medicine; Rheumatic disease; Disease; Virology; Infectious disease (medical specialty); Outbreak; Political science","score_opus":0.13594044540251254,"score_gpt":0.38292971842888124,"score_spread":0.2469892730263687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016350662","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09284709,0.0039848853,0.0013827115,0.0020057892,0.00013675743,0.0006771692,0.8859399,0.00009137199,0.012934402],"genre_scores_gemma":[0.24218991,0.004694804,0.0048474744,0.0019669593,0.00031973276,0.002178457,0.74005383,0.00016509375,0.0035837274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891073,0.0028238604,0.002160929,0.0013461467,0.0033553478,0.001206382],"domain_scores_gemma":[0.96823186,0.007100826,0.013083313,0.003065317,0.0066408524,0.0018778023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008522352,0.00060623745,0.0013121982,0.004329047,0.0007359136,0.002475346,0.00095505285,0.0009779516,0.008320089],"category_scores_gemma":[0.034936633,0.0006165419,0.001052732,0.013598565,0.0002638283,0.0023542417,0.0026535229,0.0016833473,0.0026537045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015856331,0.000152904,0.8151422,0.0013481647,0.0008187552,0.00011435753,0.00038535864,0.00048703657,0.00025872522,0.0015564337,0.15949294,0.01865744],"study_design_scores_gemma":[0.00061194785,0.000119449556,0.9250582,0.0015798229,0.000601063,0.00028655553,0.00064457813,0.0004562258,0.00029030384,0.0005558272,0.06974803,0.00004800717],"about_ca_topic_score_codex":0.027922608,"about_ca_topic_score_gemma":0.041503537,"teacher_disagreement_score":0.027922608,"about_ca_system_score_codex":0.0016098545,"about_ca_system_score_gemma":0.004364808,"threshold_uncertainty_score":0.055520117},"labels":[],"label_agreement":null},{"id":"W3028737055","doi":"10.1016/s2665-9913(20)30086-2","title":"European consensus statements for interstitial lung disease in systemic sclerosis","year":2020,"lang":"en","type":"letter","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Interstitial lung disease; Medicine; Nintedanib; Rituximab; Lung transplantation; Transplantation; Intensive care medicine; Internal medicine; Lung; Idiopathic pulmonary fibrosis; Lymphoma","score_opus":0.07231592618114392,"score_gpt":0.316498548299,"score_spread":0.24418262211785607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028737055","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007778118,0.0040065977,0.00013430351,0.946399,0.04590551,0.000014580753,0.00008676762,0.000011475887,0.0033639115],"genre_scores_gemma":[0.001952265,0.0024977354,0.00054159993,0.9239552,0.061438616,0.00009635066,0.00013012295,0.00003502252,0.009353029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97827417,0.007198661,0.0040816558,0.001207638,0.006578277,0.0026596012],"domain_scores_gemma":[0.9380768,0.034603853,0.0049867844,0.0014352113,0.01354835,0.007348976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019033486,0.0014846808,0.0027742167,0.0020066402,0.004889622,0.008722068,0.003270541,0.105646655,0.009112892],"category_scores_gemma":[0.0858317,0.0010711047,0.0033038557,0.0018260516,0.004606932,0.0054986645,0.004512178,0.054201737,0.007930371],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045138506,0.00001802451,0.0001414657,0.00013406915,0.000015113103,0.00038284188,0.00007099983,0.00004587737,0.00006656472,0.0034122637,0.9898387,0.00582883],"study_design_scores_gemma":[0.00019064575,0.000022986542,0.001061206,0.00136608,0.00005489042,0.0006441785,0.00020089,0.00022941265,0.000119648415,0.008298726,0.98775744,0.000053955384],"about_ca_topic_score_codex":0.009377257,"about_ca_topic_score_gemma":0.01287439,"teacher_disagreement_score":0.105646655,"about_ca_system_score_codex":0.008501619,"about_ca_system_score_gemma":0.016114438,"threshold_uncertainty_score":0.10065991},"labels":[],"label_agreement":null},{"id":"W3031324523","doi":"10.1016/s2665-9913(20)30066-7","title":"5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharmaceuticals UK Limited; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Secukinumab; Ankylosing spondylitis; Medicine; Measure (data warehouse); Clinical trial; Phase (matter); Internal medicine; Rheumatoid arthritis; Computer science; Data mining; Physics","score_opus":0.03062192535098186,"score_gpt":0.2818879644821985,"score_spread":0.25126603913121665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031324523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858849,0.010520918,0.00024055432,0.0004538466,0.00019317602,0.00018727279,0.0011704416,0.000047885424,0.0013009608],"genre_scores_gemma":[0.99455416,0.0016514199,0.000238228,0.0005902039,0.00023078972,0.00023745045,0.0017127463,0.000013437584,0.00077152014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987697,0.000652409,0.00008220097,0.00015445835,0.0001224722,0.00021874587],"domain_scores_gemma":[0.99816835,0.00060922484,0.00056621956,0.00016891309,0.00011885801,0.00036836634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032057639,0.0019669142,0.0031927715,0.00029574556,0.00045595894,0.001536313,0.00074377906,0.0016754494,0.0021367436],"category_scores_gemma":[0.0024303866,0.00042835766,0.0044800597,0.0003133146,0.0007751084,0.0015401162,0.00053484476,0.0031361547,0.0004897731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9433178,0.0026223466,0.014731539,0.00090935035,0.008702815,0.00013496199,0.00011672816,0.0012506704,0.002179404,0.00017937046,0.0015772074,0.024277898],"study_design_scores_gemma":[0.6809694,0.16586734,0.13075754,0.00032705936,0.013396338,0.00044055138,0.00020923585,0.0019837646,0.0018027463,0.0009731916,0.0031458198,0.0001270723],"about_ca_topic_score_codex":0.00053478463,"about_ca_topic_score_gemma":0.0012514587,"teacher_disagreement_score":0.0032057639,"about_ca_system_score_codex":0.00069037074,"about_ca_system_score_gemma":0.0005853184,"threshold_uncertainty_score":0.016953886},"labels":[],"label_agreement":null},{"id":"W3045804302","doi":"10.1016/s2665-9913(20)30217-4","title":"Making a big impact with small datasets using machine-learning approaches","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Lupus Foundation of America","keywords":"Machine learning; Artificial intelligence; Medicine; Disease; Immune system; Logistic regression; Linear discriminant analysis; Random forest; Internal medicine; Computer science; Immunology","score_opus":0.2841654152793832,"score_gpt":0.3616368716226651,"score_spread":0.0774714563432819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045804302","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026744999,0.021531917,0.8044199,0.09625663,0.008608644,0.0018044948,0.013668778,0.0090297,0.017934918],"genre_scores_gemma":[0.17559822,0.010638556,0.76135707,0.019095898,0.008423748,0.0025043073,0.017091604,0.0022640375,0.0030265127],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9503249,0.02879329,0.0029401162,0.0075786915,0.009692929,0.00067009724],"domain_scores_gemma":[0.60023475,0.32499772,0.006986876,0.051744144,0.012054888,0.0039816494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06389886,0.004065318,0.0046374043,0.009423025,0.0028299529,0.0157368,0.006745453,0.005175584,0.008854132],"category_scores_gemma":[0.28538322,0.0024093313,0.0037960187,0.0108899325,0.006093168,0.030014424,0.0138247125,0.014090562,0.0060393754],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019460873,0.0010066974,0.03905568,0.0056015793,0.0065705073,0.001811708,0.0017568546,0.06264187,0.006280286,0.11349727,0.17640784,0.5834236],"study_design_scores_gemma":[0.0003121403,0.0002548135,0.006119774,0.0012321658,0.0005328668,0.00033651217,0.0009883791,0.14360096,0.002395172,0.76591325,0.07810724,0.00020671374],"about_ca_topic_score_codex":0.0026292333,"about_ca_topic_score_gemma":0.002974296,"teacher_disagreement_score":0.06389886,"about_ca_system_score_codex":0.0022267788,"about_ca_system_score_gemma":0.0041405517,"threshold_uncertainty_score":0.33793354},"labels":[],"label_agreement":null},{"id":"W3068108655","doi":"10.1016/s2665-9913(20)30222-8","title":"Optimal length and usefulness of temporal artery biopsies in the diagnosis of giant cell arteritis: a 10-year retrospective review of medical records","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary; University of Alberta Hospital","funders":"","keywords":"Giant cell arteritis; Medicine; Medical record; Retrospective cohort study; Arteritis; Temporal artery; Radiology; Pathology; Dermatology; Vasculitis; Disease","score_opus":0.028846160309429672,"score_gpt":0.2740882727953693,"score_spread":0.24524211248593963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3068108655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937756,0.0044905413,0.00013798758,0.00008598752,0.000011994326,0.000015367907,0.00086252566,0.000004149629,0.00061590364],"genre_scores_gemma":[0.9980586,0.0011971106,0.00012002336,0.00003403153,0.000015018474,0.000009591083,0.0005194227,0.0000021891954,0.000044073902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997416,0.00066561927,0.00074582157,0.00035743983,0.000543517,0.00027155166],"domain_scores_gemma":[0.9864036,0.0042699967,0.00669767,0.00052969257,0.0016078723,0.00049105356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002010787,0.00019052355,0.0003698272,0.003348771,0.00048568146,0.0008736828,0.00045650822,0.00066298933,0.0007234783],"category_scores_gemma":[0.0098064635,0.0002976277,0.0005166336,0.0027834876,0.00052808435,0.0014032151,0.00061869924,0.00038590393,0.00022962138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009212496,0.000009617638,0.9977239,0.000034276676,0.000029296118,0.00048239037,0.0000948891,0.00001838927,0.00020456055,0.00000810421,0.000057965397,0.001244463],"study_design_scores_gemma":[0.0000041113726,0.000071671035,0.9956748,0.000054983597,0.000068037625,0.0028745343,0.00067392463,0.000101400416,0.00015039499,0.000010340012,0.00030945163,0.0000062967288],"about_ca_topic_score_codex":0.004814217,"about_ca_topic_score_gemma":0.0055966056,"teacher_disagreement_score":0.004814217,"about_ca_system_score_codex":0.0006557145,"about_ca_system_score_gemma":0.0007838118,"threshold_uncertainty_score":0.0106342435},"labels":[],"label_agreement":null},{"id":"W3081222913","doi":"10.1016/s2665-9913(20)30304-0","title":"Delving beneath the surface of hyperinflammation in COVID-19","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, Stanford University; Queen's University; University College Dublin; Queen's University Belfast","keywords":"Cytokine storm; Coronavirus disease 2019 (COVID-19); Scopus; Medicine; Immunosuppression; Immune system; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Immune dysregulation; Immunology; MEDLINE; Biology","score_opus":0.11113785677929815,"score_gpt":0.4189236220858571,"score_spread":0.30778576530655893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081222913","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18235447,0.39366317,0.0024428256,0.3683389,0.010132818,0.00036746613,0.0020461886,0.00005809868,0.040596098],"genre_scores_gemma":[0.81753844,0.06888974,0.003727082,0.08884486,0.0154150585,0.0003748591,0.001070213,0.00006623809,0.004073567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96690226,0.02474422,0.0021241987,0.0009918347,0.002927921,0.0023095151],"domain_scores_gemma":[0.9214766,0.041615985,0.014940573,0.0055440785,0.011651087,0.0047716615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036630325,0.00052560616,0.0014254019,0.0011141209,0.0014301103,0.0052392166,0.00081401324,0.0027617011,0.00783348],"category_scores_gemma":[0.058632452,0.0004201763,0.0010464471,0.0017210305,0.0028530727,0.0033265864,0.0024021424,0.005481616,0.0013026871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138206165,0.0013162111,0.23595798,0.015585345,0.0072077275,0.0010843318,0.008096296,0.000401926,0.00480677,0.03582864,0.16989078,0.5060034],"study_design_scores_gemma":[0.0033920065,0.007224523,0.45883828,0.040130258,0.0048499154,0.0027436186,0.024183664,0.00048249846,0.0030287064,0.048386313,0.40640295,0.00033734838],"about_ca_topic_score_codex":0.003035677,"about_ca_topic_score_gemma":0.0055946694,"teacher_disagreement_score":0.036630325,"about_ca_system_score_codex":0.0011677865,"about_ca_system_score_gemma":0.003346175,"threshold_uncertainty_score":0.19372195},"labels":[],"label_agreement":null},{"id":"W3087513136","doi":"10.1016/s2665-9913(20)30336-2","title":"The contribution of the observational research design to COVID-19 research","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Rheumatology Research Foundation; North Carolina GlaxoSmithKline Foundation","keywords":"Hydroxychloroquine; Medicine; Azithromycin; Randomized controlled trial; Pandemic; Medical prescription; Internal medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Disease; Pharmacology; Antibiotics","score_opus":0.6122907623710243,"score_gpt":0.5785268615989554,"score_spread":0.03376390077206892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087513136","genre_codex":"methods","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03504852,0.11476559,0.59099895,0.14891958,0.058065422,0.015459375,0.0061550173,0.0008403228,0.029747153],"genre_scores_gemma":[0.47043252,0.016335536,0.34921196,0.087465726,0.029999964,0.038242843,0.0022089134,0.0012981404,0.004804373],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.058567487,0.8516845,0.046007134,0.012555452,0.029309165,0.001876286],"domain_scores_gemma":[0.025154592,0.8609146,0.025959875,0.06783589,0.018153418,0.0019815161],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.82160103,0.0030675596,0.008916729,0.0054801945,0.005273399,0.016681943,0.010147937,0.013189036,0.007830508],"category_scores_gemma":[0.90185004,0.0050446484,0.008745863,0.010148574,0.01789726,0.012728213,0.00948903,0.016704813,0.0017404204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018102584,0.0013160851,0.15158553,0.044612404,0.05783863,0.0012457543,0.017364306,0.012573798,0.0020600045,0.39703447,0.06591005,0.23035635],"study_design_scores_gemma":[0.012819117,0.0056148195,0.08751132,0.051249135,0.0257815,0.0022231578,0.0031622464,0.04293914,0.0044744774,0.54834217,0.21397105,0.0019118815],"about_ca_topic_score_codex":0.01159599,"about_ca_topic_score_gemma":0.011755281,"teacher_disagreement_score":0.17839897,"about_ca_system_score_codex":0.010556633,"about_ca_system_score_gemma":0.027816266,"threshold_uncertainty_score":0.21999776},"labels":[],"label_agreement":null},{"id":"W3088574535","doi":"10.1016/s2665-9913(20)30339-8","title":"Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pfizer (Canada); Toronto Western Hospital","funders":"National Institute for Health and Care Research; Pfizer","keywords":"Tofacitinib; Medicine; Placebo; Psoriatic arthritis; Janus kinase inhibitor; Rheumatoid arthritis; Methotrexate; Internal medicine; Arthritis; Randomized controlled trial; Surgery","score_opus":0.02447617196090696,"score_gpt":0.28998623515423827,"score_spread":0.2655100631933313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088574535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826768,0.011987875,0.00027825873,0.00044420792,0.00055134174,0.0014602785,0.00077312154,0.0000601884,0.0017678263],"genre_scores_gemma":[0.9921737,0.0033618922,0.00046772585,0.0005450206,0.0006392927,0.0011227776,0.00063630496,0.000009338148,0.0010439755],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989065,0.00052989897,0.000109505185,0.00017238299,0.00010260509,0.00017902427],"domain_scores_gemma":[0.99840707,0.0005444713,0.00048551458,0.000107348016,0.0001075944,0.0003480408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021787882,0.0016211368,0.0039777807,0.000723296,0.0006792477,0.0011700903,0.0007668801,0.002277294,0.0048559424],"category_scores_gemma":[0.0029121006,0.0008657339,0.003388809,0.00061358034,0.0010497485,0.0014662265,0.00053565775,0.0033059746,0.00073853094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96957785,0.004340543,0.0023328445,0.001466592,0.0034119324,0.00006263641,0.00013082403,0.0001702431,0.0019414749,0.00004987884,0.0004782607,0.016037047],"study_design_scores_gemma":[0.8854663,0.09683972,0.012939025,0.0001354402,0.0028814645,0.000104031955,0.000090581445,0.00025742705,0.00030371742,0.00014656705,0.0007939856,0.00004187383],"about_ca_topic_score_codex":0.0021030547,"about_ca_topic_score_gemma":0.005062976,"teacher_disagreement_score":0.0048559424,"about_ca_system_score_codex":0.0010018302,"about_ca_system_score_gemma":0.000782533,"threshold_uncertainty_score":0.01624471},"labels":[],"label_agreement":null},{"id":"W3092030699","doi":"10.1016/s2665-9913(20)30280-0","title":"Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Agence Nationale de la Recherche; Association Française contre les Myopathies","keywords":"Double blind; Placebo; Proof of concept; Medicine; Inclusion body myositis; Phase (matter); Physical therapy; Internal medicine; Myositis; Alternative medicine; Computer science; Pathology; Physics","score_opus":0.031373451480997294,"score_gpt":0.3024497989504072,"score_spread":0.2710763474694099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092030699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94581574,0.03361779,0.0022032615,0.002261017,0.0026133726,0.0068321745,0.0024099248,0.00041406127,0.0038327493],"genre_scores_gemma":[0.9548855,0.016594281,0.0041245674,0.0039233733,0.0014906736,0.009650923,0.0024480277,0.00007694812,0.0068057347],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916327,0.00041813118,0.00005704222,0.00015094296,0.000074925905,0.00013564366],"domain_scores_gemma":[0.99929357,0.00024426333,0.00015326218,0.000050061848,0.00004922244,0.0002095437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002306438,0.0026816272,0.0049270694,0.00053549005,0.00045178647,0.0014056606,0.0011102421,0.0031604234,0.0070673246],"category_scores_gemma":[0.00196178,0.0008155004,0.0028412084,0.0005307417,0.0013915462,0.0013561008,0.00051167887,0.0034623833,0.00135582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9832478,0.001996964,0.00015670441,0.0012327209,0.0009517356,0.00003349488,0.00003975465,0.00015660969,0.002437302,0.00009694496,0.0007647443,0.008885178],"study_design_scores_gemma":[0.98452365,0.014123659,0.0004589117,0.00003362821,0.00023673684,0.000017830636,0.000008733276,0.0000993893,0.00010012929,0.0000619348,0.00032767162,0.000007879444],"about_ca_topic_score_codex":0.00082103803,"about_ca_topic_score_gemma":0.0015178004,"teacher_disagreement_score":0.0070673246,"about_ca_system_score_codex":0.0006631132,"about_ca_system_score_gemma":0.0010737721,"threshold_uncertainty_score":0.02364254},"labels":[],"label_agreement":null},{"id":"W3092497121","doi":"10.1016/s2665-9913(20)30352-0","title":"The efficacy and safety of targeting GM-CSF in arthritis","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; School of Public Health, University of California Berkeley; National Institutes of Health; Sanofi; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb","keywords":"Arthritis; Medicine; Pharmacology; Internal medicine","score_opus":0.025776624838252268,"score_gpt":0.2867619042055703,"score_spread":0.260985279367318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092497121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5690351,0.37278396,0.013714885,0.027238928,0.0012283041,0.00010050173,0.00095291703,0.00024838196,0.014697036],"genre_scores_gemma":[0.9588951,0.035294987,0.0026497548,0.0016944688,0.00046417775,0.000030024647,0.00019824153,0.00001595959,0.0007571873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991628,0.00043280577,0.00004373139,0.00006670333,0.00024776772,0.000046200963],"domain_scores_gemma":[0.9959215,0.003287119,0.0004105162,0.00014524632,0.0001440657,0.00009153689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026698187,0.00021893818,0.00051716674,0.00032161432,0.00012315536,0.0009881953,0.00035335976,0.0007452122,0.001610276],"category_scores_gemma":[0.007652031,0.00013224245,0.00071062293,0.00024835108,0.0006794682,0.0005921729,0.00025806768,0.0013378743,0.00029210435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015575811,0.000550554,0.025456062,0.0021834557,0.0017635566,0.00016883198,0.00008952236,0.04644007,0.012512253,0.01300468,0.008915962,0.8733391],"study_design_scores_gemma":[0.015071103,0.03499302,0.13678342,0.004057639,0.008507258,0.0029767572,0.00056406046,0.3236362,0.0642095,0.24182947,0.1670717,0.0002998405],"about_ca_topic_score_codex":0.0009663551,"about_ca_topic_score_gemma":0.000876296,"teacher_disagreement_score":0.0026698187,"about_ca_system_score_codex":0.0006461183,"about_ca_system_score_gemma":0.0008468977,"threshold_uncertainty_score":0.0141195655},"labels":[],"label_agreement":null},{"id":"W3093155650","doi":"10.1016/s2665-9913(20)30237-x","title":"Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Western University; Mount Sinai Hospital","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Michigan; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Placebo; Open label; Clinical endpoint; Double blind; Clinical trial; Internal medicine; Scleroderma (fungus); Surgery; Immunology","score_opus":0.10443496688843151,"score_gpt":0.33645644239700867,"score_spread":0.23202147550857716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093155650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98754,0.0043690787,0.00093653804,0.0004993497,0.0007313589,0.0032255377,0.0008942233,0.000120698096,0.0016832816],"genre_scores_gemma":[0.9866022,0.0021440408,0.0017235567,0.0008571338,0.0007966924,0.0046933233,0.0010294687,0.000028866218,0.0021247056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981925,0.0010283634,0.000112688365,0.00027653592,0.00013258525,0.000257331],"domain_scores_gemma":[0.99728906,0.0011953796,0.0003954248,0.00029900626,0.00019171141,0.0006294263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038262315,0.0023398653,0.0045518833,0.0006767652,0.0006495186,0.00159482,0.0012281956,0.0032212362,0.007820294],"category_scores_gemma":[0.0036314446,0.00093038037,0.0030042885,0.000515616,0.0022144734,0.0023426195,0.00071088853,0.0038529176,0.001544538],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9893596,0.0028696456,0.000213469,0.00024975726,0.000322399,0.000018514991,0.000029700688,0.0001124034,0.00090079795,0.00004469453,0.00015717029,0.0057217814],"study_design_scores_gemma":[0.9569037,0.0417095,0.00061590405,0.000019020454,0.0002002328,0.000014958926,0.000009835513,0.00013726043,0.00015209118,0.000074122116,0.0001548218,0.00000857122],"about_ca_topic_score_codex":0.00085299736,"about_ca_topic_score_gemma":0.0009075082,"teacher_disagreement_score":0.007820294,"about_ca_system_score_codex":0.0008175993,"about_ca_system_score_gemma":0.0011958042,"threshold_uncertainty_score":0.026161551},"labels":[],"label_agreement":null},{"id":"W3096695579","doi":"10.1016/s2665-9913(20)30382-9","title":"Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Weill Cornell Medical College; Università di Pisa; Directorate for Biological Sciences; Syddansk Universitet; Oxford University Hospitals NHS Foundation Trust; Odense Universitetshospital; Gentofte Hospital; Daiichi Sankyo Europe; University College London Hospitals NHS Foundation Trust; Bayer HealthCare; Guy's and St Thomas' NHS Foundation Trust; University of Manchester; Università degli Studi di Torino; Universidad de Navarra; University College London; McGill University Health Centre; McGill University; National Institute for Health and Care Research; University of Oxford; Hospital for Special Surgery; Pfizer; Bristol-Myers Squibb","keywords":"Hydroxychloroquine; Medicine; Antiphospholipid syndrome; Rheumatoid arthritis; Chloroquine; Pandemic; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Internal medicine; Immunology; Malaria","score_opus":0.07128924253385732,"score_gpt":0.3885835697761517,"score_spread":0.3172943272422944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096695579","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011246494,0.008939964,0.000045346438,0.9814703,0.0068485714,0.00000858608,0.00005760259,0.000006519231,0.001498419],"genre_scores_gemma":[0.018887343,0.008844025,0.00027427168,0.9373073,0.03389104,0.000030535342,0.00005698506,0.000015446323,0.00069306314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98639244,0.0067676147,0.002869911,0.0008792771,0.0019027076,0.0011880173],"domain_scores_gemma":[0.94258904,0.03420063,0.005339414,0.0012108963,0.009671501,0.006988518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009629622,0.00045246576,0.0015812975,0.00090444763,0.002518701,0.0037590172,0.0015375152,0.032846406,0.0039812434],"category_scores_gemma":[0.070643716,0.0007069161,0.0014233252,0.0016817302,0.002390398,0.004207129,0.0018761149,0.024135811,0.0019475931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065583043,0.00013082167,0.019809699,0.00080334715,0.00014963775,0.005429554,0.0016465067,0.00009358333,0.0005052071,0.0022983875,0.91383153,0.05464596],"study_design_scores_gemma":[0.0013230842,0.0007373043,0.025677767,0.007969823,0.0004416956,0.010860759,0.007092243,0.00041252936,0.00049783464,0.008198479,0.936566,0.00022241623],"about_ca_topic_score_codex":0.011089383,"about_ca_topic_score_gemma":0.0135080265,"teacher_disagreement_score":0.032846406,"about_ca_system_score_codex":0.0031168554,"about_ca_system_score_gemma":0.005967396,"threshold_uncertainty_score":0.050926924},"labels":[],"label_agreement":null},{"id":"W3115055441","doi":"10.1016/s2665-9913(20)30422-7","title":"Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; Bristol-Myers Squibb Canada; National Institutes of Health; Rheumatology Research Foundation; AstraZeneca","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Cohort; Disease; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cohort study; Internal medicine; Virology; Outbreak; Infectious disease (medical specialty)","score_opus":0.060739563221639564,"score_gpt":0.4031144733786875,"score_spread":0.3423749101570479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115055441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937902,0.0018643234,0.00017553543,0.00022867863,0.000040906318,0.000018185045,0.003229815,0.000006094271,0.0006462859],"genre_scores_gemma":[0.996302,0.0006383039,0.00016798338,0.000105957406,0.0000494151,0.00003039482,0.0024614406,0.00000774712,0.00023671747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974837,0.0006309787,0.00037988197,0.0006685333,0.00025136207,0.0005855878],"domain_scores_gemma":[0.9932721,0.0008112336,0.0031104987,0.0011648679,0.00074663,0.0008946752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026286307,0.000417272,0.00066695304,0.0010685653,0.0007560325,0.0015043883,0.00077065,0.00088697387,0.0014669948],"category_scores_gemma":[0.0064451336,0.00059539004,0.0015799437,0.003150488,0.00038878835,0.0012447496,0.0014475094,0.0016879966,0.00030698822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046414632,0.00004062265,0.9969704,0.000032201147,0.00062405586,0.000069496804,0.00011247015,0.000029784063,0.00016356945,0.000054261996,0.00042059325,0.0010182997],"study_design_scores_gemma":[0.000028134235,0.000112911046,0.9987809,0.000020662766,0.00019499718,0.0001536743,0.00023896022,0.00006414822,0.000025473535,0.000032774424,0.00033897973,0.00000842062],"about_ca_topic_score_codex":0.014997093,"about_ca_topic_score_gemma":0.014899568,"teacher_disagreement_score":0.014997093,"about_ca_system_score_codex":0.0006478806,"about_ca_system_score_gemma":0.0008276953,"threshold_uncertainty_score":0.029819608},"labels":[],"label_agreement":null},{"id":"W3139210094","doi":"10.1016/s2665-9913(21)00010-2","title":"Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pfizer (Canada); Toronto Western Hospital","funders":"National Institute for Health and Care Research; Catholic Medical Center; Pfizer","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Tolerability; Adverse effect; Placebo; Janus kinase inhibitor; Internal medicine; Methotrexate; Psoriasis; Incidence (geometry); Arthritis; Surgery; Rheumatoid arthritis; Dermatology","score_opus":0.016223543105305688,"score_gpt":0.27814298382100794,"score_spread":0.2619194407157023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139210094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741542,0.020891383,0.0002363124,0.00033515776,0.00012459274,0.00015444763,0.0023298266,0.000029790564,0.0017443955],"genre_scores_gemma":[0.9933448,0.0028942444,0.00017873367,0.00032095172,0.00018831824,0.00010811361,0.0022960322,0.0000090071,0.00065977377],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99884135,0.00045380573,0.000111728856,0.00020614405,0.00019255884,0.00019446372],"domain_scores_gemma":[0.997535,0.0006903645,0.00086673314,0.0002462282,0.0002304126,0.00043122238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035870126,0.0010683404,0.0025933697,0.0005450298,0.0005355237,0.0013837485,0.0006140756,0.0010996845,0.001993758],"category_scores_gemma":[0.0031786542,0.0004144366,0.0038911947,0.0007107903,0.0005388311,0.0012729306,0.00051864644,0.0020303426,0.00042383606],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81138355,0.0019581774,0.093825616,0.0016846521,0.01663302,0.00023630682,0.00019411615,0.0014558447,0.0036955895,0.00015823216,0.0018108365,0.066964164],"study_design_scores_gemma":[0.27194035,0.08516846,0.60255057,0.0004862046,0.029947598,0.00070731755,0.00026497914,0.0015746255,0.0013980642,0.0007953397,0.00500703,0.00015943137],"about_ca_topic_score_codex":0.0013948539,"about_ca_topic_score_gemma":0.0027655868,"teacher_disagreement_score":0.0035870126,"about_ca_system_score_codex":0.00070550235,"about_ca_system_score_gemma":0.0007311615,"threshold_uncertainty_score":0.018970132},"labels":[],"label_agreement":null},{"id":"W3143732278","doi":"10.1016/s2665-9913(21)00062-x","title":"The role of antirheumatics in patients with COVID-19","year":2021,"lang":"en","type":"review","venue":"The Lancet Rheumatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Medicine; Internal medicine; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.08006059398889029,"score_gpt":0.45042626375917416,"score_spread":0.37036566977028385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143732278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041504347,0.99970895,0.000008266504,0.00009148454,0.0000556668,0.000001993461,0.000011482138,6.135757e-7,0.00007998341],"genre_scores_gemma":[0.0011968213,0.99828535,0.000067090885,0.0002445133,0.0001279952,0.0000065225995,0.000022644568,5.6675407e-7,0.00004851344],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982926,0.00054728444,0.0004670009,0.00020744423,0.00037401548,0.000111691974],"domain_scores_gemma":[0.9933902,0.004814324,0.0011660401,0.000078244266,0.00042974754,0.00012134367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003973872,0.0009481429,0.0042977775,0.0030123177,0.00023614684,0.0016915118,0.0012151182,0.0019130872,0.00463926],"category_scores_gemma":[0.007201823,0.0005098904,0.0025178457,0.003150599,0.0006072327,0.0011811424,0.00088110816,0.0020837619,0.0006082179],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012438798,0.00007506461,0.0011337964,0.2130667,0.0042219395,0.00013046345,0.00008694502,0.00022727659,0.00057514606,0.0017449656,0.013547564,0.7639462],"study_design_scores_gemma":[0.0025854218,0.0012053626,0.016531605,0.2980148,0.029749654,0.0018553652,0.00042485123,0.00028238646,0.00070642756,0.0032920835,0.645203,0.00014898505],"about_ca_topic_score_codex":0.0027732672,"about_ca_topic_score_gemma":0.0065692295,"teacher_disagreement_score":0.00463926,"about_ca_system_score_codex":0.0008824525,"about_ca_system_score_gemma":0.0024454133,"threshold_uncertainty_score":0.02101612},"labels":[],"label_agreement":null},{"id":"W3154979932","doi":"10.1016/s2665-9913(21)00060-6","title":"Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Alberta Health Services; Université du Québec à Montréal; McGill University; University of Calgary; Concordia University; Ontario Brain Institute; University of Ottawa; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Scleroderma Society of Ontario; McGill University","keywords":"Anxiety; Medicine; Mental health; Psychological intervention; Randomized controlled trial; Population; Cohort; Intervention (counseling); Physical therapy; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.015791867513190967,"score_gpt":0.271047976713301,"score_spread":0.25525610920011005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154979932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986232,0.0038867325,0.0005394905,0.00060900685,0.0010501662,0.005662281,0.0006943929,0.0001000697,0.0012260398],"genre_scores_gemma":[0.98429984,0.0020721052,0.0016178361,0.0006528108,0.0006529615,0.007947431,0.0006144538,0.000016332311,0.0021263275],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985274,0.0005717735,0.00015692746,0.00033259398,0.00012750328,0.0002838009],"domain_scores_gemma":[0.9982863,0.0005692258,0.00029329734,0.00012117464,0.000099104655,0.00063078763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002007432,0.0024575067,0.005666189,0.00064262585,0.0010941114,0.0016060454,0.0014829576,0.0039268574,0.008264486],"category_scores_gemma":[0.0037092823,0.0011265959,0.0037839813,0.00051093,0.0019177081,0.0015303005,0.0011847307,0.004342679,0.0010826528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98379636,0.006648371,0.00030560538,0.0009732364,0.0012448144,0.000025297824,0.00006881832,0.00012579848,0.00042347284,0.000051869516,0.00017243763,0.0061639533],"study_design_scores_gemma":[0.96224993,0.035508182,0.0011437885,0.00006817148,0.00061387307,0.000008397219,0.000025836187,0.00013601186,0.00007451946,0.000057697966,0.00010249525,0.000011067766],"about_ca_topic_score_codex":0.00467683,"about_ca_topic_score_gemma":0.0053110793,"teacher_disagreement_score":0.008264486,"about_ca_system_score_codex":0.00129387,"about_ca_system_score_gemma":0.0015022255,"threshold_uncertainty_score":0.027647436},"labels":[],"label_agreement":null},{"id":"W3173649223","doi":"10.1016/s2665-9913(21)00105-3","title":"Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Sacroiliitis; Medicine; BASDAI; Psoriatic arthritis; Ankylosing spondylitis; Post-hoc analysis; Internal medicine; Placebo; Arthritis; Spondylitis; Physical therapy; Surgery; Pathology","score_opus":0.01602143525873485,"score_gpt":0.2904512544520611,"score_spread":0.27442981919332626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173649223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928145,0.0039690197,0.00046692946,0.00020473164,0.00024886095,0.0003869767,0.0011283238,0.000039524653,0.00074110186],"genre_scores_gemma":[0.99578494,0.0009959928,0.00047316737,0.00018724817,0.0002010499,0.00042457145,0.0009844797,0.000032853786,0.0009156979],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9933195,0.0047503905,0.00035578528,0.00061198004,0.0003231635,0.0006391109],"domain_scores_gemma":[0.99146324,0.0052775657,0.001256572,0.0009380938,0.00041598652,0.0006483977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009267273,0.00249047,0.007233966,0.00051138026,0.0006332307,0.0018063361,0.0011524656,0.0014152768,0.002852876],"category_scores_gemma":[0.0060712257,0.00097579055,0.0095719,0.0006843259,0.0012576723,0.0018643049,0.0010301734,0.0034654487,0.00044737622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9754885,0.0009390435,0.0031769613,0.00038025243,0.012750994,0.00003630763,0.00005287376,0.0005403062,0.0012690859,0.00004418396,0.00028054984,0.0050409934],"study_design_scores_gemma":[0.6125716,0.23939607,0.084295124,0.00017146634,0.0543543,0.0001771059,0.00034342796,0.0026422788,0.003305789,0.00048522418,0.0020706719,0.00018692881],"about_ca_topic_score_codex":0.0008626053,"about_ca_topic_score_gemma":0.0021600195,"teacher_disagreement_score":0.009267273,"about_ca_system_score_codex":0.00092658395,"about_ca_system_score_gemma":0.0014142825,"threshold_uncertainty_score":0.049010575},"labels":[],"label_agreement":null},{"id":"W3186491363","doi":"10.1016/s2665-9913(21)00033-3","title":"Calcinosis cutis universalis secondary to scleroderma-polymyositis overlap syndrome","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Calcinosis cutis; Calcification; Pathology; Dermatomyositis; Skin biopsy; Buttocks; Calcinosis; Dermatology; Biopsy; Anatomy","score_opus":0.01758262185952026,"score_gpt":0.25852196368926494,"score_spread":0.2409393418297447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186491363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379291,0.02070901,0.0011083299,0.0049132267,0.00031708824,0.00008013416,0.00026535004,0.00020524129,0.034472506],"genre_scores_gemma":[0.9959829,0.0016454094,0.00019618674,0.0005207618,0.000514188,0.000007979652,0.00007847211,0.00000953967,0.0010445347],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999408,0.00008881833,0.00007439346,0.00009235927,0.0001298456,0.00020667528],"domain_scores_gemma":[0.99835277,0.00064702774,0.0005065534,0.00010597784,0.0001031294,0.00028455775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036360256,0.00096933945,0.00096135354,0.0014514461,0.00087930623,0.00095291284,0.0004937278,0.0023395815,0.0041371984],"category_scores_gemma":[0.0026618482,0.00041515764,0.00050575106,0.0013909724,0.0013258007,0.0005696819,0.0009557674,0.0010962313,0.00061493507],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006843776,0.00012336137,0.09504803,0.0004899399,0.00020010966,0.8673799,0.00038327274,0.00028874024,0.007887372,0.00339756,0.0035088654,0.020608442],"study_design_scores_gemma":[0.00021374096,0.00017907484,0.08359262,0.00012656186,0.000129087,0.90971,0.00027847022,0.00053337053,0.00078962604,0.0011236733,0.0033063642,0.000017380207],"about_ca_topic_score_codex":0.0027108726,"about_ca_topic_score_gemma":0.0023717596,"teacher_disagreement_score":0.0041371984,"about_ca_system_score_codex":0.00072320603,"about_ca_system_score_gemma":0.00068168255,"threshold_uncertainty_score":0.013840258},"labels":[],"label_agreement":null},{"id":"W3186673974","doi":"10.1016/s2665-9913(21)00175-2","title":"Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; McMaster University; Queen's University; Impact","funders":"Cilag; Vasculitis Clinical Research Consortium; Roche; Vasculitis Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Biogen; European League Against Rheumatism; Gilead Sciences; Department of Health and Aged Care, Australian Government; Sanofi; Meso Scale Diagnostics; AbbVie; National Institute for Health and Care Research; Novartis; Pfizer; American College of Rheumatology Research and Education Foundation","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Health care; Family medicine; Virology; Political science; Disease; Outbreak; Pathology; Infectious disease (medical specialty)","score_opus":0.04316571071813616,"score_gpt":0.34719013619445477,"score_spread":0.3040244254763186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186673974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255085,0.00039988788,0.00006846016,0.0010252063,0.00005037452,0.00004600566,0.004363208,0.000004830614,0.0014910498],"genre_scores_gemma":[0.99573576,0.00033423046,0.00012276559,0.0009844977,0.000046058572,0.0000658141,0.0022931544,0.000006800608,0.00041099367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752873,0.0008545339,0.00027339516,0.00033093122,0.00029701964,0.00071539247],"domain_scores_gemma":[0.99531543,0.0008035273,0.0017934258,0.00039098097,0.00046869754,0.0012279964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024804638,0.00042697074,0.00050654274,0.00056908367,0.00078170194,0.0013397684,0.00071758445,0.0020423215,0.0023772165],"category_scores_gemma":[0.007104436,0.0005723856,0.0018799728,0.0015812011,0.00074178434,0.0015601038,0.0030771187,0.003373834,0.000509858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021268241,0.00017601698,0.99618775,0.000041859723,0.00013895489,0.000043831606,0.0007607042,0.00003999863,0.00009388163,0.000024781253,0.00051508995,0.0017644414],"study_design_scores_gemma":[0.000005786603,0.000089555164,0.9989097,0.000013801321,0.000020100077,0.00001925776,0.00073096517,0.000018172143,0.000012296626,0.000006732118,0.00016881655,0.0000048052934],"about_ca_topic_score_codex":0.057590727,"about_ca_topic_score_gemma":0.06639564,"teacher_disagreement_score":0.057590727,"about_ca_system_score_codex":0.00093266706,"about_ca_system_score_gemma":0.0013069398,"threshold_uncertainty_score":0.11451101},"labels":[],"label_agreement":null},{"id":"W3214568069","doi":"10.1016/s2665-9913(21)00316-7","title":"Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Arthritis Patient Alliance","funders":"Manchester Biomedical Research Centre; Institut National de la Santé et de la Recherche Médicale; Sorbonne Université; McMaster University; European League Against Rheumatism; National Institute for Health and Care Research; School of Medicine, Boston University; University of Otago; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institute on Handicapped Research; Versus Arthritis; Utah Department of Health; Metro North Hospital and Health Service; American College of Rheumatology Research and Education Foundation","keywords":"Polymyalgia rheumatica; Medicine; Coronavirus disease 2019 (COVID-19); Rheumatology; Internal medicine; Retrospective cohort study; Giant cell arteritis; Vasculitis; Pandemic; Systemic vasculitis; Cohort; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pathology; Disease","score_opus":0.01665686063384866,"score_gpt":0.28354426657676096,"score_spread":0.2668874059429123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214568069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686736,0.0005593142,0.00009403406,0.00006731953,0.000020208363,0.000018518047,0.0019189444,0.0000049541572,0.0004493453],"genre_scores_gemma":[0.9970701,0.0002721036,0.000084378145,0.000068104964,0.000040495346,0.000027842902,0.0022812048,0.0000063344232,0.00014945924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.000336726,0.00020152343,0.0006195374,0.00023975864,0.00042541276],"domain_scores_gemma":[0.9969891,0.00034438883,0.0014499981,0.00037375657,0.0002581232,0.0005846684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010664333,0.0005910376,0.0009162273,0.0012037324,0.0008086193,0.0015495333,0.0009008165,0.0011107784,0.0016512446],"category_scores_gemma":[0.0035122458,0.00082514394,0.0011308554,0.0024925594,0.00053754274,0.0017357781,0.0015794345,0.0016021499,0.0004017885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016660058,0.000030788044,0.99883896,0.000012445464,0.00013697668,0.00011781358,0.000051429448,0.000021609809,0.000087590626,0.000023203937,0.00020995934,0.00030270437],"study_design_scores_gemma":[0.000027755741,0.00010205339,0.9986072,0.00001481573,0.000096020536,0.00046872738,0.00030315234,0.00010479803,0.000028556433,0.000031123756,0.00020500073,0.000010685892],"about_ca_topic_score_codex":0.007485479,"about_ca_topic_score_gemma":0.008446094,"teacher_disagreement_score":0.007485479,"about_ca_system_score_codex":0.0007003329,"about_ca_system_score_gemma":0.00067888567,"threshold_uncertainty_score":0.014883816},"labels":[],"label_agreement":null},{"id":"W3215650992","doi":"10.1016/s2665-9913(21)00318-0","title":"Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Multiple Sclerosis Society of Canada; Jewish General Hospital","funders":"National Cancer Institute; Lady Davis Institute for Medical Research; Canadian Institutes of Health Research; Fondation de l'Hôpital général juif; Scleroderma Society of Ontario; Russian Science Foundation; Jewish General Hospital; Fonds de Recherche du Québec - Santé; Arthritis Society; McGill University","keywords":"Medicine; Cohort; Physical therapy; Cross-sectional study; Rheumatology; Rheumatism; Internal medicine; Cohort study; Pathology","score_opus":0.051100232457860904,"score_gpt":0.314213446622995,"score_spread":0.2631132141651341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215650992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992099,0.00008210327,0.000045696223,0.00004742271,0.000008408137,0.000014683879,0.0004394301,0.0000018863063,0.00015026444],"genre_scores_gemma":[0.9987613,0.00008939467,0.000110726236,0.00007879232,0.000018402703,0.000040037346,0.00071620167,0.0000030574884,0.00018203378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990108,0.000340419,0.000069997855,0.00024336841,0.00013775135,0.00019753755],"domain_scores_gemma":[0.99855655,0.00019345433,0.0005103477,0.00017539656,0.00015988539,0.00040444772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001319068,0.00061231764,0.00070244615,0.00050396955,0.00085298193,0.0011508634,0.00084574375,0.0011159983,0.0013874057],"category_scores_gemma":[0.002126967,0.0008508915,0.0008897993,0.00114811,0.00046198044,0.00091425906,0.001116589,0.0014809818,0.0003073575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053394836,0.0002689342,0.9973902,0.00001885972,0.000263888,0.00010913999,0.00019126205,0.000029313984,0.00042486915,0.000022126513,0.00022676268,0.00052067573],"study_design_scores_gemma":[0.00004760034,0.00016062726,0.9992083,0.000005682231,0.00007208813,0.00009010819,0.00026061363,0.000070276925,0.00001579512,0.000010594314,0.000053466003,0.000004890692],"about_ca_topic_score_codex":0.014619571,"about_ca_topic_score_gemma":0.020211732,"teacher_disagreement_score":0.014619571,"about_ca_system_score_codex":0.0006189629,"about_ca_system_score_gemma":0.0005999794,"threshold_uncertainty_score":0.029068947},"labels":[],"label_agreement":null},{"id":"W4200124088","doi":"10.1016/s2665-9913(21)00363-5","title":"Mental health before and during the pandemic in people with systemic sclerosis","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Calgary; Hotchkiss Brain Institute; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Scleroderma Society of Ontario; Canadian Institutes of Health Research; Mitacs; McGill University; Boehringer Ingelheim; Scleroderma Foundation-Tri-State","keywords":"Mental health; Anxiety; Depression (economics); Psychiatry; Medicine; Pandemic; Population; Coronavirus disease 2019 (COVID-19); Psychology; Family medicine; Environmental health; Disease","score_opus":0.018843474950454943,"score_gpt":0.25620517676389437,"score_spread":0.23736170181343944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200124088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9101829,0.008490445,0.000059670292,0.069659635,0.0018943514,0.000043025244,0.001339932,0.000008013738,0.008322066],"genre_scores_gemma":[0.9869191,0.003861435,0.000048857142,0.0072671566,0.000821788,0.000046604033,0.00039630887,0.000005948358,0.0006328095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988588,0.0003447829,0.00006531524,0.00007774357,0.00008570784,0.0005675252],"domain_scores_gemma":[0.99758315,0.00033818578,0.00048741314,0.000059381844,0.00026566666,0.0012661429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008476203,0.00018114464,0.0004783561,0.0005300352,0.0020466158,0.0015950743,0.0004126077,0.0022496404,0.0026430818],"category_scores_gemma":[0.0060582883,0.00027187893,0.0006816757,0.0010179819,0.0009134223,0.0020330641,0.0016407861,0.0051493878,0.0002044607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013268167,0.0006897809,0.8983268,0.0005596938,0.0004517757,0.0016226767,0.019226594,0.00017864506,0.000487537,0.0015332076,0.025489038,0.050107397],"study_design_scores_gemma":[0.000047639554,0.00026993762,0.96960115,0.00046556562,0.000092162954,0.0003199398,0.023609575,0.00007521842,0.000037085872,0.000748972,0.0046911757,0.000041570423],"about_ca_topic_score_codex":0.09376627,"about_ca_topic_score_gemma":0.1256062,"teacher_disagreement_score":0.09376627,"about_ca_system_score_codex":0.002300443,"about_ca_system_score_gemma":0.0024117404,"threshold_uncertainty_score":0.186441},"labels":[],"label_agreement":null},{"id":"W4200411358","doi":"10.1016/s2665-9913(21)00359-3","title":"Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Medpace; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Prednisone; Internal medicine; Clinical endpoint; Open label; Rheumatology; Prospective cohort study; Physical therapy; Clinical trial; Rituximab","score_opus":0.044832243580684675,"score_gpt":0.3008634728828124,"score_spread":0.25603122930212774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200411358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657043,0.016800204,0.0035452726,0.0007871823,0.0010652506,0.007637994,0.0017582168,0.00015736996,0.0025441959],"genre_scores_gemma":[0.97635865,0.0060360236,0.004990624,0.001981819,0.0010658366,0.005785921,0.0013618101,0.000052058993,0.0023673822],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9977016,0.0011486172,0.00012966458,0.0003244978,0.0002701769,0.00042547547],"domain_scores_gemma":[0.99641293,0.0011404036,0.0007845515,0.00043533638,0.00036506506,0.0008617458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007143763,0.0023829874,0.004605981,0.00041571487,0.00068746647,0.0025269852,0.001288426,0.0027279647,0.0055777906],"category_scores_gemma":[0.0032555799,0.00090786885,0.0033335786,0.00055929844,0.00214661,0.001891403,0.00055703236,0.0036177626,0.0014798068],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9299375,0.021130849,0.0018884429,0.0021480874,0.0024247796,0.000112170135,0.00013491465,0.00039364328,0.010712315,0.00023998691,0.0009693635,0.029907933],"study_design_scores_gemma":[0.6162074,0.3679058,0.008395714,0.00020749906,0.0027173436,0.0001734406,0.00008844153,0.00042308174,0.0012257148,0.00035009708,0.0022520362,0.000053381522],"about_ca_topic_score_codex":0.0006996245,"about_ca_topic_score_gemma":0.0009632183,"teacher_disagreement_score":0.007143763,"about_ca_system_score_codex":0.0011322016,"about_ca_system_score_gemma":0.0026957248,"threshold_uncertainty_score":0.037780285},"labels":[],"label_agreement":null},{"id":"W4205473666","doi":"10.1016/s2665-9913(21)00416-1","title":"Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cohort study; Cohort; Multiple sclerosis; Connective tissue disease; Disease","score_opus":0.04607995496519998,"score_gpt":0.3048780745207641,"score_spread":0.2587981195555641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205473666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222434,0.00094379165,0.00032705336,0.00027362033,0.00008769928,0.000054006312,0.0051094517,0.000015788979,0.00096429983],"genre_scores_gemma":[0.99123174,0.0006525858,0.0004614306,0.00032057057,0.00010473745,0.00012127415,0.0051316707,0.000038202994,0.0019379436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979265,0.00047697427,0.0002029334,0.0006505348,0.00020760065,0.0005354742],"domain_scores_gemma":[0.99633044,0.00039508202,0.0010635623,0.0010992014,0.0004991652,0.0006124895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022686643,0.0012410341,0.0014771093,0.0007970299,0.0018543528,0.002589421,0.0010023161,0.0015671686,0.0037556721],"category_scores_gemma":[0.003119132,0.0017132815,0.0027398902,0.0023955673,0.0006150098,0.0013815864,0.0017544016,0.0026956801,0.0012208691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004467763,0.0002401643,0.9837647,0.0001086048,0.0044901427,0.0006535746,0.00045553126,0.00007188491,0.0009747734,0.00028897106,0.0023003449,0.0021835896],"study_design_scores_gemma":[0.0008326882,0.0008281751,0.9892224,0.00009083536,0.0034953791,0.0009965383,0.0015275817,0.0002244157,0.00014760482,0.00027209957,0.002297106,0.00006516497],"about_ca_topic_score_codex":0.014733929,"about_ca_topic_score_gemma":0.01996366,"teacher_disagreement_score":0.014733929,"about_ca_system_score_codex":0.0006177733,"about_ca_system_score_gemma":0.0012176428,"threshold_uncertainty_score":0.029296339},"labels":[],"label_agreement":null},{"id":"W4206577746","doi":"10.1016/s2665-9913(21)00331-3","title":"Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding?","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Cognition; Medicine; Neuropsychology; Disease; Systemic lupus erythematosus; Lupus erythematosus; Psychology; Intensive care medicine; Immunology; Psychiatry; Pathology","score_opus":0.056148352017342196,"score_gpt":0.3148720535273704,"score_spread":0.2587237015100282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206577746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019376795,0.7834166,0.00029564658,0.20632984,0.006182282,0.000008856364,0.00012366066,0.000028933135,0.0016764061],"genre_scores_gemma":[0.029689532,0.84572595,0.0011004349,0.07078428,0.051813953,0.00005759308,0.00017323172,0.000016065538,0.00063896534],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.996851,0.0011458871,0.0005310444,0.00034313006,0.0006900642,0.00043880809],"domain_scores_gemma":[0.96522284,0.022894358,0.0027921933,0.0007876141,0.005638084,0.0026647844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010431201,0.0017031166,0.0066050915,0.002612537,0.0013954311,0.008127395,0.0027821963,0.008891246,0.004589862],"category_scores_gemma":[0.028317694,0.0006494506,0.0020992076,0.002074541,0.003994558,0.01173935,0.0029522914,0.01716464,0.0015394812],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013603084,0.0008185145,0.03288178,0.0121607445,0.0020963964,0.0015042364,0.0016972781,0.0006844797,0.00073553255,0.018082527,0.22371128,0.7042669],"study_design_scores_gemma":[0.0018961725,0.0015741725,0.13006353,0.06351592,0.0051050074,0.0052567157,0.010229264,0.002379008,0.00052496017,0.17875814,0.59961176,0.0010854304],"about_ca_topic_score_codex":0.012178157,"about_ca_topic_score_gemma":0.01549742,"teacher_disagreement_score":0.012178157,"about_ca_system_score_codex":0.00272863,"about_ca_system_score_gemma":0.007498907,"threshold_uncertainty_score":0.055166125},"labels":[],"label_agreement":null},{"id":"W4210636953","doi":"10.1016/s2665-9913(21)00354-4","title":"The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Placebo; Visual analogue scale; Physical therapy; Internal medicine; Quality of life (healthcare); Dermatology Life Quality Index; Arthritis; Population; Disease; Alternative medicine","score_opus":0.008783294639384149,"score_gpt":0.2716300310795096,"score_spread":0.26284673644012546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210636953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877977,0.006939761,0.0004102147,0.0010193028,0.00083464687,0.0009725846,0.00061753305,0.000066842564,0.0013414373],"genre_scores_gemma":[0.993008,0.0018820099,0.00056761503,0.0008916698,0.00042928077,0.0012712252,0.00058539794,0.000016779106,0.0013480322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99799275,0.0013100805,0.000118935975,0.00022845104,0.00011450359,0.00023528827],"domain_scores_gemma":[0.9977586,0.000945025,0.000518161,0.00020759148,0.00011071608,0.0004598837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032878502,0.0021249843,0.004080106,0.00032715732,0.00058734114,0.0014256197,0.0008554392,0.0022021323,0.005685433],"category_scores_gemma":[0.0036095849,0.000729673,0.004173501,0.00040438992,0.0016298913,0.0014062022,0.0006617656,0.0048432765,0.0007557797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9905606,0.0010995908,0.000605734,0.00036005522,0.0015252744,0.000030240908,0.000036577585,0.00018844812,0.0006935092,0.000065091896,0.00028618402,0.0045486647],"study_design_scores_gemma":[0.95292646,0.041327044,0.0037365132,0.000042348645,0.0010492872,0.000028832537,0.000029043575,0.00023226209,0.00014767855,0.0001419504,0.00032057913,0.00001795163],"about_ca_topic_score_codex":0.0009461012,"about_ca_topic_score_gemma":0.001745541,"teacher_disagreement_score":0.005685433,"about_ca_system_score_codex":0.00079268636,"about_ca_system_score_gemma":0.0009328662,"threshold_uncertainty_score":0.019019604},"labels":[],"label_agreement":null},{"id":"W4210838916","doi":"10.1016/s2665-9913(22)00002-9","title":"The changing face of psoriatic arthritis","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Leeds Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Psoriatic arthritis; Medicine; Arthritis; Inflammatory arthritis; Disease; Psoriasis; Clinical trial; Physical therapy; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.01907933491286095,"score_gpt":0.27025983347405463,"score_spread":0.2511804985611937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210838916","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002033386,0.19261305,0.00015308209,0.79100865,0.009840008,0.0000042940956,0.00014202663,0.00001780342,0.0041877246],"genre_scores_gemma":[0.106629156,0.38754818,0.0012131536,0.41281247,0.087962344,0.000045656096,0.00025441742,0.000059871007,0.0034747676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866563,0.006126223,0.0012693102,0.0008106586,0.0038019253,0.0013355836],"domain_scores_gemma":[0.95196545,0.028635008,0.0036880192,0.0013119924,0.006509592,0.007890022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01922718,0.00048276526,0.0020509944,0.0018969488,0.0021616223,0.00861354,0.0016129101,0.012297658,0.0137989465],"category_scores_gemma":[0.048002232,0.0005405747,0.00081654434,0.002304771,0.0070298403,0.01456953,0.0037873336,0.014382545,0.0024637077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008287079,0.00021615827,0.006689263,0.005348398,0.00038166906,0.00076356926,0.0027168824,0.00025054312,0.0010965354,0.060380008,0.4937411,0.42758712],"study_design_scores_gemma":[0.00025611446,0.00023731394,0.02385046,0.0060759378,0.0001991998,0.0012526221,0.009827594,0.00025227005,0.00022841964,0.08748548,0.8701733,0.00016127569],"about_ca_topic_score_codex":0.0069639804,"about_ca_topic_score_gemma":0.0170776,"teacher_disagreement_score":0.01922718,"about_ca_system_score_codex":0.0038508284,"about_ca_system_score_gemma":0.007956265,"threshold_uncertainty_score":0.10168427},"labels":[],"label_agreement":null},{"id":"W4210850748","doi":"10.1016/s2665-9913(22)00001-7","title":"COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; McMaster University; Impact","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Vaccination; Coronavirus disease 2019 (COVID-19); Medicine; Disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; 2019-20 coronavirus outbreak; Perception; Alliance; Rheumatic disease; Rheumatology; Immunology; Virology; Internal medicine; Infectious disease (medical specialty); Outbreak; Psychology; Political science","score_opus":0.0684808675348845,"score_gpt":0.3536367688781509,"score_spread":0.2851559013432664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210850748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944174,0.00030893207,0.000055658256,0.0013609219,0.00002343529,0.00003683947,0.0019468853,0.0000034924494,0.0018462683],"genre_scores_gemma":[0.9976125,0.00028447178,0.000057586312,0.00063821796,0.00002496984,0.000045489356,0.00092168985,0.000004881243,0.00041032277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965474,0.0012423012,0.00038551766,0.00028526256,0.00081373873,0.00072574266],"domain_scores_gemma":[0.9903799,0.002227835,0.0044265585,0.00030175984,0.0009975308,0.0016664293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041582296,0.00023497357,0.00047500842,0.00078978884,0.00061469397,0.001247707,0.0005494169,0.0012759288,0.0021033648],"category_scores_gemma":[0.015431375,0.00042114593,0.0009560333,0.0017171288,0.0005690286,0.0021268285,0.0019459771,0.0022334568,0.0005520428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110381305,0.00028550896,0.9921543,0.000062187086,0.000110734305,0.00002484668,0.0019370842,0.00006544949,0.00007151058,0.00007019368,0.0012784234,0.0038293782],"study_design_scores_gemma":[0.000010495227,0.00011606332,0.99649674,0.000031758464,0.000021138574,0.000020883379,0.0025949196,0.00007804193,0.000026098996,0.000033780056,0.000561656,0.000008523564],"about_ca_topic_score_codex":0.03982009,"about_ca_topic_score_gemma":0.030440865,"teacher_disagreement_score":0.03982009,"about_ca_system_score_codex":0.0008674477,"about_ca_system_score_gemma":0.0014402329,"threshold_uncertainty_score":0.079176605},"labels":[],"label_agreement":null},{"id":"W4211026324","doi":"10.1016/s2665-9913(21)00326-x","title":"Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University; McGill University Health Centre","funders":"Centre Hospitalier Universitaire de Rennes; Agence Nationale de la Recherche","keywords":"Medicine; Mesenchymal stem cell; Bone marrow; Stromal cell; Cell therapy; Scleroderma (fungus); Internal medicine; Pathology; Stem cell","score_opus":0.06829737147226164,"score_gpt":0.30340055073872785,"score_spread":0.2351031792664662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211026324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909855,0.0036679488,0.0013609425,0.00035946947,0.0001828774,0.0012870709,0.00085590885,0.00012316003,0.001177254],"genre_scores_gemma":[0.99010414,0.0020645764,0.0018268897,0.0008893646,0.00019185046,0.0014910938,0.0014791415,0.00004365842,0.0019093164],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99932766,0.0003122492,0.000033641674,0.00011104607,0.00009477165,0.00012067763],"domain_scores_gemma":[0.99916244,0.00020775174,0.00018055552,0.00009945988,0.000068660614,0.00028120956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018574294,0.0015751078,0.0018818158,0.00036627604,0.0004173701,0.00150539,0.0007472877,0.0017358061,0.0030703738],"category_scores_gemma":[0.0011621331,0.0005049969,0.0016849153,0.00034129812,0.0012399482,0.00090960966,0.0002747314,0.0035170007,0.0007895525],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64798445,0.088198826,0.0023553956,0.0018534148,0.0016354619,0.00029318975,0.0003675474,0.0037661952,0.14088646,0.0004456405,0.0037610356,0.10845235],"study_design_scores_gemma":[0.26779246,0.7110674,0.0056818016,0.000060642647,0.0005652206,0.00025168303,0.00008112871,0.0011681553,0.010257327,0.00037010424,0.0026604582,0.00004370376],"about_ca_topic_score_codex":0.00041232814,"about_ca_topic_score_gemma":0.0008903264,"teacher_disagreement_score":0.0030703738,"about_ca_system_score_codex":0.00065954827,"about_ca_system_score_gemma":0.0011385877,"threshold_uncertainty_score":0.01027143},"labels":[],"label_agreement":null},{"id":"W4214479583","doi":"10.1016/s2665-9913(22)00008-x","title":"Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Leeds Biomedical Research Centre; National Institute for Health and Care Research; AbbVie","keywords":"Medicine; Adalimumab; Methotrexate; Psoriatic arthritis; Clinical endpoint; Internal medicine; Open label; Arthritis; Adverse effect; Clinical trial; Surgery; Rheumatoid arthritis","score_opus":0.041086109749305634,"score_gpt":0.34386203961406203,"score_spread":0.3027759298647564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214479583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989373,0.0032768168,0.00057943293,0.00021239383,0.0004792361,0.004754346,0.00035576973,0.000059795297,0.00090920704],"genre_scores_gemma":[0.98301655,0.0020224494,0.0021865778,0.00056394754,0.0008775536,0.009148803,0.00058979855,0.000021030426,0.0015733669],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945259,0.0038340043,0.00046885622,0.0005425032,0.00028285777,0.00034588407],"domain_scores_gemma":[0.9929789,0.0032170715,0.0016344315,0.0007014059,0.00039852952,0.0010696204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006683076,0.002514137,0.0052036233,0.0012521937,0.0005185651,0.0016573028,0.0016055745,0.0034094525,0.0068955817],"category_scores_gemma":[0.0075375927,0.001247631,0.0044310046,0.00076440413,0.0018490015,0.0020909072,0.0007960204,0.002425746,0.0009708358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98449194,0.009181918,0.00028880764,0.00040335068,0.00056923483,0.000022733167,0.000039930306,0.00011224511,0.0008294261,0.000032073276,0.00008830946,0.0039400333],"study_design_scores_gemma":[0.82786787,0.17008336,0.001099568,0.000021029255,0.00035656182,0.00001754294,0.000013497643,0.00014710378,0.00016619882,0.00006271665,0.00015220502,0.00001233067],"about_ca_topic_score_codex":0.0008592096,"about_ca_topic_score_gemma":0.00087638706,"teacher_disagreement_score":0.0068955817,"about_ca_system_score_codex":0.00127051,"about_ca_system_score_gemma":0.0013349709,"threshold_uncertainty_score":0.035343945},"labels":[],"label_agreement":null},{"id":"W4223977625","doi":"10.1016/s2665-9913(22)00096-0","title":"Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of Manitoba; Women's College Hospital; University of British Columbia; Public Health Ontario; SickKids Foundation; University of Toronto; University of Calgary; Institute for Clinical Evaluative Sciences; McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Hospital for Sick Children; University of British Columbia; University of Toronto; Institute for Clinical Evaluative Sciences; Public Health Agency of Canada; Department of Family and Community Medicine, University of Toronto; Ministry of Health -Singapore; Cancer Care Ontario; Arthritis Society; Eli Lilly and Company","keywords":"Medicine; Ankylosing spondylitis; Rheumatoid arthritis; Population; Immunology; Logistic regression; Immune system; Psoriatic arthritis; Inflammatory arthritis; Disease; Internal medicine; Environmental health","score_opus":0.017798994264585716,"score_gpt":0.2846416819037958,"score_spread":0.2668426876392101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223977625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785548,0.0016019202,0.00016635776,0.00047445972,0.000050307826,0.00008641448,0.016654411,0.000023047716,0.0023883572],"genre_scores_gemma":[0.99547774,0.0004246271,0.000096598604,0.0001556318,0.000014678352,0.0000378093,0.002962956,0.0000056706294,0.00082426437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997666,0.00023881186,0.0002232285,0.00046101955,0.0005837643,0.0008273022],"domain_scores_gemma":[0.99693644,0.00017021729,0.00097086607,0.00015097023,0.0009599011,0.0008116099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010114021,0.00074826786,0.0008557494,0.0010841851,0.0017767705,0.0011423157,0.0020329084,0.0010477883,0.001742686],"category_scores_gemma":[0.0031277612,0.0007199202,0.001988514,0.004074555,0.0009050317,0.0006439706,0.0011136847,0.0012202587,0.00024322474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002039439,0.00002374401,0.99727696,0.000040078812,0.00026642453,0.000034122284,0.00017208915,0.00011793892,0.00008315294,0.00003987979,0.0008109547,0.00093075994],"study_design_scores_gemma":[0.00002568615,0.000053552558,0.99889296,0.000024264069,0.000107320804,0.000021607144,0.00036859105,0.0001470769,0.00001660532,0.000010364532,0.00032287886,0.000009185182],"about_ca_topic_score_codex":0.9894274,"about_ca_topic_score_gemma":0.9916413,"teacher_disagreement_score":0.019608375,"about_ca_system_score_codex":0.019608375,"about_ca_system_score_gemma":0.025424058,"threshold_uncertainty_score":0.14226943},"labels":[],"label_agreement":null},{"id":"W4283658992","doi":"10.1016/s2665-9913(22)00182-5","title":"Addressing fatigue in inflammatory rheumatic diseases","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Psychological intervention; Scopus; Rheumatoid arthritis; Rheumatology; Physical therapy; Internal medicine; Clinical trial; MEDLINE; Psychiatry","score_opus":0.07613077899228238,"score_gpt":0.33936804442025953,"score_spread":0.26323726542797715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283658992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004506079,0.78123796,0.00059534446,0.17511727,0.018548168,0.000048381382,0.00015513998,0.000056336707,0.01973538],"genre_scores_gemma":[0.087418,0.70260465,0.0022090655,0.11428687,0.078456216,0.00013470124,0.00025424102,0.000031791118,0.01460445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888474,0.000498401,0.000107176624,0.00006745165,0.00023987282,0.00020242955],"domain_scores_gemma":[0.9965724,0.0018102998,0.00045435323,0.00007902534,0.00053724775,0.0005467511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00258086,0.0004967838,0.0009628825,0.00076807477,0.00057577837,0.0015448711,0.00046890855,0.0020058001,0.010158404],"category_scores_gemma":[0.007306014,0.00017347185,0.0006968344,0.00031570197,0.00076157943,0.0012254314,0.0014250076,0.0029345863,0.0018636261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045014816,0.00021492946,0.0021178848,0.008610417,0.00036493954,0.00023696618,0.0004128911,0.00018285344,0.0015148424,0.004905923,0.22618504,0.7548031],"study_design_scores_gemma":[0.0009784556,0.0014064569,0.02226409,0.013206412,0.0006927965,0.0011000275,0.0010041879,0.00022348862,0.00049239123,0.01459557,0.9439796,0.00005648231],"about_ca_topic_score_codex":0.0016006229,"about_ca_topic_score_gemma":0.0057326597,"teacher_disagreement_score":0.010158404,"about_ca_system_score_codex":0.0006795598,"about_ca_system_score_gemma":0.0016863357,"threshold_uncertainty_score":0.03398317},"labels":[],"label_agreement":null},{"id":"W4287733511","doi":"10.1016/s2665-9913(22)00183-7","title":"Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Astellas Pharma","keywords":"Medicine; GERD; Disease; Intensive care medicine; Proton-pump inhibitor; Population; Scleroderma (fungus); Gastro-; Systemic disease; Adverse effect; Reflux; Internal medicine; Immunology","score_opus":0.04594750796018773,"score_gpt":0.2984454156150138,"score_spread":0.25249790765482605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287733511","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009778078,0.6924419,0.001117727,0.275795,0.02657407,0.000017793654,0.000054872962,0.00008367653,0.0029370764],"genre_scores_gemma":[0.021585913,0.7641841,0.0043654568,0.09995752,0.107041836,0.00005458518,0.000068463836,0.000050637092,0.0026915225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973884,0.00082063966,0.00047645124,0.00024803728,0.000867757,0.00019878571],"domain_scores_gemma":[0.9881003,0.006278444,0.00092791684,0.00036026502,0.0033049707,0.0010280133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009150761,0.0012920462,0.003427375,0.0013939423,0.0006623861,0.0050081597,0.0016430238,0.0077095,0.0031139646],"category_scores_gemma":[0.015353745,0.0004970142,0.0014947299,0.0011477612,0.0029623515,0.006359149,0.0019615532,0.015905906,0.001661734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014609615,0.00030990734,0.0014341385,0.008407689,0.0009022199,0.00104166,0.00038658443,0.0017509172,0.0020288634,0.028292853,0.30590215,0.6480821],"study_design_scores_gemma":[0.0016928216,0.0010498386,0.004001568,0.010377561,0.0008930451,0.0016916031,0.00066941255,0.0014469187,0.00043249503,0.03027914,0.9472747,0.00019092925],"about_ca_topic_score_codex":0.001965475,"about_ca_topic_score_gemma":0.00501196,"teacher_disagreement_score":0.009150761,"about_ca_system_score_codex":0.0020834664,"about_ca_system_score_gemma":0.0036070924,"threshold_uncertainty_score":0.04839444},"labels":[],"label_agreement":null},{"id":"W4287734667","doi":"10.1016/s2665-9913(22)00192-8","title":"Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"Centers for Disease Control and Prevention; Brigham Research Institute; National Institutes of Health; European League Against Rheumatism; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Justus Liebig Universität Gießen; National Institute on Handicapped Research; Utah Department of Health; Rheumatology Research Foundation; American College of Rheumatology Research and Education Foundation; U.S. Department of Veterans Affairs","keywords":"Medicine; Observational study; Demography; Logistic regression; Population; Disease; Odds ratio; Odds; Coronavirus disease 2019 (COVID-19); Environmental health; Internal medicine; Infectious disease (medical specialty)","score_opus":0.3378094701053095,"score_gpt":0.40130033520972447,"score_spread":0.06349086510441498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287734667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926785,0.001681228,0.00024317596,0.00021373948,0.000045305576,0.000022255943,0.004410892,0.0000048045904,0.0007001036],"genre_scores_gemma":[0.9961541,0.0006089443,0.00016005123,0.00011302811,0.00004451797,0.0000386649,0.0026330247,0.000004068172,0.0002435382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777967,0.00073125813,0.00038478375,0.00042583921,0.00021889908,0.0004595795],"domain_scores_gemma":[0.99472433,0.0007136402,0.0026395626,0.00076911825,0.0004951715,0.00065808825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014958377,0.00048469685,0.000802407,0.0010423324,0.00079204154,0.0012901851,0.00087244774,0.0015537203,0.001832751],"category_scores_gemma":[0.0061011924,0.0007992499,0.0024827998,0.0035832417,0.00037961753,0.0009609226,0.0016649496,0.0021792536,0.0003336345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023088911,0.000056296754,0.99824905,0.000039574974,0.000632034,0.000042886066,0.00006337352,0.000027987382,0.00005281776,0.00003434237,0.0001832555,0.00038746346],"study_design_scores_gemma":[0.000022394039,0.00007597039,0.9990133,0.00002690472,0.00020472746,0.00007980269,0.00023178161,0.000079575,0.000014780679,0.0000342776,0.00020928682,0.000007251791],"about_ca_topic_score_codex":0.02559968,"about_ca_topic_score_gemma":0.024866646,"teacher_disagreement_score":0.02559968,"about_ca_system_score_codex":0.0006150966,"about_ca_system_score_gemma":0.0007887039,"threshold_uncertainty_score":0.050901353},"labels":[],"label_agreement":null},{"id":"W4293255190","doi":"10.1016/s2665-9913(21)00348-9","title":"Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Monoclonal; Multiple myeloma; Pathology; Monoclonal gammopathy; Waldenstrom macroglobulinemia; Lymphoma; Monoclonal antibody; Immunology; Antibody","score_opus":0.05379788697716307,"score_gpt":0.3575408716735238,"score_spread":0.3037429846963607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293255190","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013056584,0.47745085,0.0014652484,0.48164973,0.03333948,0.000033860953,0.00012497332,0.00011605813,0.00451417],"genre_scores_gemma":[0.020759378,0.45331565,0.004461744,0.2992866,0.21850748,0.000089129535,0.00027636476,0.000076576456,0.0032270239],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945163,0.0014718004,0.0014418942,0.000463309,0.001665977,0.0004406893],"domain_scores_gemma":[0.9498399,0.027352052,0.0025711402,0.0011826173,0.0137210805,0.0053332676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008746827,0.0016208497,0.0058879945,0.0027896718,0.0020436,0.008060157,0.0029726094,0.021137748,0.0044253496],"category_scores_gemma":[0.03284784,0.0014420446,0.0022441938,0.0013198415,0.004093391,0.013348741,0.0019761955,0.026218863,0.0038035312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037204885,0.0003896776,0.012266459,0.0052153557,0.00042921663,0.0081436755,0.00070716377,0.00033563795,0.001255126,0.004217967,0.6511463,0.31552145],"study_design_scores_gemma":[0.00051951205,0.00034845405,0.022252463,0.03395301,0.00088413485,0.042255163,0.009576851,0.0012314605,0.0003522446,0.04518591,0.8428309,0.00061006466],"about_ca_topic_score_codex":0.0056140814,"about_ca_topic_score_gemma":0.011654598,"teacher_disagreement_score":0.021137748,"about_ca_system_score_codex":0.00230493,"about_ca_system_score_gemma":0.0052295364,"threshold_uncertainty_score":0.04625821},"labels":[],"label_agreement":null},{"id":"W4293685692","doi":"10.1016/s2665-9913(22)00185-0","title":"Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Axial spondyloarthritis; Medicine; Sacroiliac joint; Radiography; Radiology; Magnetic resonance imaging; Nuclear medicine; Sacroiliitis; Internal medicine; Arthritis; Secukinumab; Psoriatic arthritis","score_opus":0.010963143805703067,"score_gpt":0.25405929553555984,"score_spread":0.24309615172985677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293685692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706095,0.0021298875,0.000028009525,0.00012652262,0.00003442022,0.00002362362,0.000104092236,0.000005469612,0.00048692714],"genre_scores_gemma":[0.9988714,0.0004338965,0.00009605702,0.000063067324,0.000038336995,0.000021626593,0.00011335999,0.0000014727933,0.00036062306],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996631,0.00012431707,0.000034935463,0.00005592572,0.00003561428,0.00008605699],"domain_scores_gemma":[0.9992895,0.0001697535,0.00023918884,0.000037648333,0.00006148076,0.00020237837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008228167,0.00043660233,0.0009969567,0.0001930861,0.00018501376,0.0003829963,0.00022095285,0.0006130648,0.001293062],"category_scores_gemma":[0.0015791218,0.00020706926,0.00060854235,0.00018661842,0.00024656855,0.00043917468,0.00020995416,0.000866208,0.00021028193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5851853,0.009563382,0.19927017,0.0012918682,0.002329759,0.0009358392,0.0007508625,0.0017289333,0.03755641,0.000059820548,0.0014839846,0.15984361],"study_design_scores_gemma":[0.013900957,0.10786828,0.87275547,0.00008859312,0.00082078914,0.00047719467,0.00028426034,0.0005637493,0.00207834,0.000066815206,0.0010439135,0.000051636303],"about_ca_topic_score_codex":0.001210494,"about_ca_topic_score_gemma":0.0026228451,"teacher_disagreement_score":0.001293062,"about_ca_system_score_codex":0.0003136057,"about_ca_system_score_gemma":0.00028360257,"threshold_uncertainty_score":0.0043514967},"labels":[],"label_agreement":null},{"id":"W4296577975","doi":"10.1016/s2665-9913(22)00253-3","title":"Let's talk about sex in interstitial lung disease","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Interstitial lung disease; Medicine; Idiopathic pulmonary fibrosis; Internal medicine; Rheumatoid arthritis; Disease; Usual interstitial pneumonia; Lung; Pulmonary fibrosis; Rheumatology; Pathology","score_opus":0.013895207340190325,"score_gpt":0.27394998437452717,"score_spread":0.2600547770343368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296577975","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036172706,0.18330751,0.0000991935,0.65187776,0.15794104,0.0000055395167,0.00006173207,0.000021916108,0.0063235504],"genre_scores_gemma":[0.010584171,0.08192923,0.00015604722,0.5258562,0.36871988,0.000025950041,0.00004622505,0.000042555526,0.012639771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970131,0.0013218942,0.00023419004,0.00028249438,0.0007810464,0.00036727672],"domain_scores_gemma":[0.9891155,0.008089888,0.00053083495,0.00030347361,0.0008502979,0.0011101016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053680292,0.0010776524,0.0019401792,0.0018023393,0.0026128278,0.005283634,0.0011592186,0.016290912,0.014477636],"category_scores_gemma":[0.012685238,0.0005706857,0.0015532278,0.000951057,0.0056838994,0.007945087,0.0030249401,0.021154458,0.0038603311],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017900174,0.000043229695,0.0010202496,0.0009311395,0.00018856976,0.0004638066,0.0007442337,0.00007141469,0.00026784893,0.016521465,0.93716145,0.04240758],"study_design_scores_gemma":[0.00018722654,0.00010870794,0.0016202412,0.0017898708,0.00014450494,0.0007566996,0.0012021088,0.000052657844,0.000087081724,0.01624346,0.9777566,0.000050903087],"about_ca_topic_score_codex":0.0031783734,"about_ca_topic_score_gemma":0.004774155,"teacher_disagreement_score":0.016290912,"about_ca_system_score_codex":0.001913672,"about_ca_system_score_gemma":0.0019836107,"threshold_uncertainty_score":0.04843253},"labels":[],"label_agreement":null},{"id":"W4296579066","doi":"10.1016/s2665-9913(22)00258-2","title":"Treating post-menopausal women with symptomatic hand osteoarthritis with hormone replacement therapy","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Hormone replacement therapy (female-to-male); Medicine; Post menopausal; Osteoarthritis; Hormone therapy; Estrogen replacement therapy; Menopause; Physical therapy; Internal medicine; Breast cancer; Cancer; Alternative medicine; Testosterone (patch)","score_opus":0.010323944405325747,"score_gpt":0.2391029349263661,"score_spread":0.22877899052104037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296579066","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2622258,0.6686238,0.00076754205,0.028877567,0.004053378,0.00022672105,0.0006083512,0.00008426922,0.034532536],"genre_scores_gemma":[0.7301857,0.24105969,0.001554262,0.0129332915,0.0052792844,0.000167974,0.00042898877,0.000011256753,0.008379626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980634,0.000051645857,0.000025154079,0.00001768911,0.00006026696,0.000038943203],"domain_scores_gemma":[0.99959904,0.0001767242,0.00011167912,0.000012338448,0.00003972983,0.000060590002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044573628,0.00020732648,0.00054055074,0.00024909616,0.00021294785,0.00051297323,0.00020451237,0.0006203868,0.003159773],"category_scores_gemma":[0.001770947,0.00013523964,0.00061159115,0.00027074103,0.00025529225,0.00018740284,0.00023103127,0.00058403227,0.00054892537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081111,0.0011656065,0.050095335,0.009425143,0.0018029531,0.0037302591,0.0007081191,0.0004898292,0.019601323,0.0009858111,0.03695599,0.86692846],"study_design_scores_gemma":[0.014698524,0.027575167,0.63445926,0.008432271,0.004533836,0.017951993,0.0040974,0.0008088887,0.004040182,0.0043926877,0.27887315,0.00013676351],"about_ca_topic_score_codex":0.0019112381,"about_ca_topic_score_gemma":0.008370553,"teacher_disagreement_score":0.003159773,"about_ca_system_score_codex":0.00026822393,"about_ca_system_score_gemma":0.00069129514,"threshold_uncertainty_score":0.0105704665},"labels":[],"label_agreement":null},{"id":"W4307647609","doi":"10.1016/s2665-9913(22)00309-5","title":"Predicting outcomes in systemic sclerosis by skin involvement and autoantibodies","year":2022,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Scleroderma (fungus); Medicine; Autoantibody; Dermatology; Rheumatology; Progressive systemic sclerosis; Multiple sclerosis; Immunology; Internal medicine; Antibody; RAYNAUD DISEASE","score_opus":0.0299300082902184,"score_gpt":0.2611005357863222,"score_spread":0.23117052749610378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307647609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949826,0.0043094466,0.00034420672,0.0016284547,0.00024187153,0.000013306944,0.00081233564,0.000021551874,0.0031306013],"genre_scores_gemma":[0.99757737,0.0007353155,0.00019740936,0.00022919549,0.0004125606,0.000008199107,0.0004971791,0.0000048131988,0.00033799038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983347,0.00072237843,0.0001650855,0.00021672944,0.00023783921,0.00032340083],"domain_scores_gemma":[0.99182546,0.0031359596,0.0024178675,0.00044685183,0.00065355987,0.0015201578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023905253,0.0007934334,0.0009618839,0.0011741649,0.0004198908,0.0015433759,0.00070102204,0.0014441092,0.002290878],"category_scores_gemma":[0.0083848685,0.0003859236,0.000977145,0.0014226991,0.00051875866,0.0012513853,0.0010606075,0.0025192627,0.0006995292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033228844,0.00005134938,0.99471456,0.000025582802,0.00020099322,0.000062590574,0.000025545647,0.00013906376,0.00008905837,0.000034020002,0.00045389152,0.0038710565],"study_design_scores_gemma":[0.00005326155,0.00032332083,0.99652416,0.000057235273,0.0003140333,0.00036236993,0.00016849917,0.0009828878,0.00012963056,0.0006052209,0.0004593018,0.000020180303],"about_ca_topic_score_codex":0.0021633923,"about_ca_topic_score_gemma":0.0031989585,"teacher_disagreement_score":0.0023905253,"about_ca_system_score_codex":0.00038530654,"about_ca_system_score_gemma":0.0005450145,"threshold_uncertainty_score":0.012642443},"labels":[],"label_agreement":null},{"id":"W4327905433","doi":"10.1016/s2665-9913(23)00063-2","title":"Patient–researcher co-presentation of research results to people living with systemic sclerosis","year":2023,"lang":"en","type":"letter","venue":"The Lancet Rheumatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of the Fraser Valley; Jewish General Hospital; McGill University; Multiple Sclerosis Society of Canada","funders":"","keywords":"Scopus; Medicine; Clinical trial; Presentation (obstetrics); Alternative medicine; MEDLINE; Family medicine; Medical education; Psychology; Internal medicine; Political science; Surgery","score_opus":0.2707759730913277,"score_gpt":0.47109480729514763,"score_spread":0.2003188342038199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327905433","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072394973,0.0012106752,0.0018570035,0.9754616,0.008010723,0.00011508552,0.000022644224,0.000024400842,0.006058303],"genre_scores_gemma":[0.17028876,0.0019568498,0.0035168016,0.801413,0.015417757,0.00084501575,0.000028843435,0.00006909579,0.006463833],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.79165334,0.16742426,0.014164839,0.0036287897,0.015889293,0.0072395126],"domain_scores_gemma":[0.5687263,0.35053566,0.02022752,0.009068176,0.030618621,0.020823684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06985269,0.00055480236,0.0014067884,0.0012592023,0.01069952,0.005955948,0.0016849763,0.04193271,0.009493637],"category_scores_gemma":[0.29558712,0.0012034178,0.0013459988,0.0009535849,0.0073793964,0.0059001795,0.0077895084,0.029741244,0.0029727772],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007419685,0.00034924192,0.02056474,0.001985255,0.00033928448,0.040855233,0.07927598,0.00027995298,0.004166059,0.020647977,0.7417914,0.08900282],"study_design_scores_gemma":[0.000587461,0.0010443293,0.012114287,0.0041877376,0.0002548,0.04274409,0.121792085,0.0025548874,0.0017589392,0.03634915,0.7762659,0.00034629242],"about_ca_topic_score_codex":0.0015196031,"about_ca_topic_score_gemma":0.0021828546,"teacher_disagreement_score":0.06985269,"about_ca_system_score_codex":0.0055673136,"about_ca_system_score_gemma":0.010295024,"threshold_uncertainty_score":0.3694207},"labels":[],"label_agreement":null},{"id":"W4360991431","doi":"10.1016/s2665-9913(23)00059-0","title":"Reconciling immunotherapy and autoimmunity: not for the faint of heart","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rheumatoid arthritis; Immune system; Immunotherapy; Cancer; Adverse effect; Immune checkpoint; Cancer immunotherapy; Immunology; Adjuvant; Oncology; Internal medicine","score_opus":0.06685285596376572,"score_gpt":0.3337102290731903,"score_spread":0.2668573731094246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360991431","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084117474,0.18847312,0.0016800646,0.77276057,0.03201418,0.000010177209,0.000097183736,0.000092714625,0.004030875],"genre_scores_gemma":[0.048293307,0.12026582,0.0038820964,0.65323913,0.16545276,0.00010502616,0.00016239722,0.0002582014,0.008341249],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878703,0.0054197144,0.0009010431,0.0013216119,0.003392821,0.0010945675],"domain_scores_gemma":[0.93670905,0.041185006,0.0040138434,0.0048558847,0.007664146,0.0055719125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029585596,0.0015764785,0.005554306,0.0026105375,0.0037045735,0.010864573,0.0031412274,0.022322861,0.0148240905],"category_scores_gemma":[0.05163071,0.0009672822,0.001650098,0.0012994969,0.02093702,0.035230838,0.009211002,0.042105764,0.0072254953],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009155857,0.0003355266,0.0037776704,0.0024901303,0.0009860988,0.0007274112,0.0012973166,0.00059587415,0.0013291345,0.23411968,0.59998536,0.15344033],"study_design_scores_gemma":[0.00039103598,0.0002646303,0.001808741,0.002709887,0.00030072144,0.0006951883,0.0021271587,0.00036332992,0.0003078376,0.49856955,0.4922845,0.00017752027],"about_ca_topic_score_codex":0.0016748282,"about_ca_topic_score_gemma":0.003127195,"teacher_disagreement_score":0.029585596,"about_ca_system_score_codex":0.003645258,"about_ca_system_score_gemma":0.0073019685,"threshold_uncertainty_score":0.15646547},"labels":[],"label_agreement":null},{"id":"W4380301205","doi":"10.1016/s2665-9913(23)00122-4","title":"Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis","year":2023,"lang":"en","type":"review","venue":"The Lancet Rheumatology","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR School for Primary Care Research; Foundation for Research in Rheumatology; Keele University; National Institute for Health and Care Research; Arthritis Society; Dutch Arthritis Society; Chartered Society of Physiotherapy Charitable Trust","keywords":"Meta-analysis; Osteoarthritis; Physical therapy; Medicine; Physical medicine and rehabilitation; Systematic review; MEDLINE; Alternative medicine; Internal medicine","score_opus":0.27003637145104387,"score_gpt":0.3940549512349113,"score_spread":0.12401857978386743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380301205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00981968,0.9840184,0.0027179448,0.0004017965,0.00044841453,0.0013321989,0.0007632583,0.00006712418,0.0004312529],"genre_scores_gemma":[0.5047198,0.46793976,0.012532238,0.002199511,0.0007278448,0.009230936,0.0017790023,0.00012509445,0.00074583734],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.93425435,0.044255123,0.012617605,0.004187933,0.0037553213,0.00092959666],"domain_scores_gemma":[0.9120311,0.07208597,0.00909762,0.0030127233,0.0032574313,0.0005151857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05669946,0.004019978,0.024218177,0.007996886,0.0008848896,0.00475335,0.0032391732,0.0034531706,0.0037681046],"category_scores_gemma":[0.12394974,0.0023589402,0.06067262,0.006782491,0.0015798504,0.0032784706,0.002812062,0.0031624157,0.00038109766],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026403998,0.000032433276,0.003609675,0.16974756,0.8168155,0.00007813262,0.000097283446,0.0004188077,0.00012989862,0.00018766365,0.00029457264,0.005948054],"study_design_scores_gemma":[0.0009420452,0.0002084791,0.0021812469,0.012178932,0.9829542,0.00005090917,0.000032226057,0.00020077844,0.00011950092,0.00042611745,0.0006833407,0.000022244703],"about_ca_topic_score_codex":0.005004886,"about_ca_topic_score_gemma":0.008689222,"teacher_disagreement_score":0.05669946,"about_ca_system_score_codex":0.0034051018,"about_ca_system_score_gemma":0.0045276554,"threshold_uncertainty_score":0.299859},"labels":[],"label_agreement":null},{"id":"W4382045292","doi":"10.1016/s2665-9913(23)00129-7","title":"Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H2020 European Research Council; Horizon 2020; European Research Council; Arthritis Society; ReumaNederland; Dutch Arthritis Society","keywords":"Medicine; Tenosynovitis; Rheumatoid arthritis; Synovitis; Arthritis; Tendon; Inflammation; Surgery; Internal medicine","score_opus":0.03127173362433015,"score_gpt":0.33348910746049315,"score_spread":0.302217373836163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382045292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996445,0.000095406285,0.000042533935,0.000011436449,0.0000023066061,0.000003670739,0.0001240167,0.0000015899827,0.00007443469],"genre_scores_gemma":[0.9996159,0.00005976565,0.000051936684,0.000009359205,0.0000078434805,0.000004111978,0.00019335635,0.000002029126,0.000055654556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988079,0.00036416805,0.00014127782,0.00035928644,0.00014998914,0.00017729694],"domain_scores_gemma":[0.99711514,0.0006595472,0.0011774161,0.0004931896,0.00023187751,0.00032282903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012058107,0.00062515895,0.0006911603,0.001055575,0.0006730288,0.0010830768,0.0007453905,0.00076579856,0.0016475337],"category_scores_gemma":[0.003943458,0.0008242273,0.0007780085,0.0012771678,0.00062345545,0.000783739,0.00079655263,0.0007087418,0.0003291574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005260098,0.0000648225,0.9970511,0.000012324193,0.00022135103,0.00027239445,0.00014647302,0.000023899616,0.0009241863,0.000012720111,0.000049944792,0.00069485756],"study_design_scores_gemma":[0.000024533863,0.00013860728,0.9987091,0.000004249788,0.00008542475,0.00062044844,0.00022051123,0.00008334201,0.000046051784,0.00001167467,0.000050853287,0.0000053150475],"about_ca_topic_score_codex":0.006298393,"about_ca_topic_score_gemma":0.0064106453,"teacher_disagreement_score":0.006298393,"about_ca_system_score_codex":0.00030555105,"about_ca_system_score_gemma":0.00036729444,"threshold_uncertainty_score":0.012523472},"labels":[],"label_agreement":null},{"id":"W4385211381","doi":"10.1016/s2665-9913(23)00164-9","title":"Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"ZonMw; Universiteit Leiden; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Leflunomide; Placebo; Internal medicine; Subclinical infection; Clinical trial; Arthritis; Physical therapy; Alternative medicine; Pathology","score_opus":0.07240260048119584,"score_gpt":0.34758226643478585,"score_spread":0.27517966595359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385211381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8967998,0.032276306,0.024923174,0.005980877,0.002627616,0.0033869003,0.013310455,0.0006393476,0.020055465],"genre_scores_gemma":[0.986888,0.0008937987,0.00305249,0.0018661758,0.00051755103,0.0011912838,0.002287556,0.00017573271,0.0031273896],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9007124,0.0866835,0.0027995547,0.0041682366,0.0028362907,0.002800062],"domain_scores_gemma":[0.8258308,0.14212659,0.012762983,0.015238683,0.0016197074,0.0024210613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057327505,0.0021979923,0.00824909,0.000775138,0.0005281921,0.00316704,0.0032207142,0.003297885,0.016339147],"category_scores_gemma":[0.10556297,0.0009031137,0.019382572,0.0013712915,0.0017220622,0.0028744598,0.0017788446,0.005086336,0.0017653856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70606303,0.00093635824,0.04916634,0.0057148356,0.1856096,0.00076470943,0.00044794418,0.004502645,0.004422803,0.004562963,0.008471519,0.029337185],"study_design_scores_gemma":[0.23166823,0.08781067,0.29867375,0.001785963,0.29964256,0.0012087986,0.000948582,0.02265006,0.006225533,0.022818701,0.02604134,0.0005258549],"about_ca_topic_score_codex":0.0009806976,"about_ca_topic_score_gemma":0.0011049496,"teacher_disagreement_score":0.057327505,"about_ca_system_score_codex":0.000822897,"about_ca_system_score_gemma":0.0015449426,"threshold_uncertainty_score":0.30318046},"labels":[],"label_agreement":null},{"id":"W4385212269","doi":"10.1016/s2665-9913(23)00121-2","title":"Fatigue in patients with ANCA-associated vasculitis: is avacopan the answer?","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microscopic polyangiitis; Medicine; Vasculitis; Anti-neutrophil cytoplasmic antibody; Granulomatosis with polyangiitis; Autoantibody; Internal medicine; Proteinase 3; Rapidly progressive glomerulonephritis; Disease; Immunology; Dermatology; Gastroenterology; Antibody","score_opus":0.022001185074848727,"score_gpt":0.26443466840655494,"score_spread":0.24243348333170622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385212269","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04169421,0.74760205,0.0004867005,0.18908294,0.009464171,0.000051832943,0.0005786799,0.00007302586,0.010966361],"genre_scores_gemma":[0.38943768,0.44691277,0.0012051634,0.084965825,0.073691435,0.00013594219,0.00079426786,0.000043358625,0.0028136305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989969,0.00029315418,0.00018011169,0.00012492569,0.00020251602,0.00020231932],"domain_scores_gemma":[0.9962069,0.0017911945,0.0007088238,0.000082927334,0.0006504334,0.00055962795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017883698,0.0005452912,0.002951441,0.0007066965,0.0005635507,0.0017474822,0.0006782011,0.0041135494,0.0047692116],"category_scores_gemma":[0.009703013,0.00037893254,0.0008876946,0.0010005997,0.0007548612,0.0023776193,0.0006073948,0.0040937327,0.0010817715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046699047,0.00047055323,0.18032582,0.0067981645,0.0015733695,0.0033235059,0.00078169646,0.00042795314,0.001035033,0.002123989,0.16950676,0.62896323],"study_design_scores_gemma":[0.0042647608,0.003025905,0.7294195,0.021326488,0.0032984805,0.014841522,0.0043412717,0.0014601233,0.00028972808,0.016678832,0.20056932,0.00048415907],"about_ca_topic_score_codex":0.0030053372,"about_ca_topic_score_gemma":0.0051601003,"teacher_disagreement_score":0.0047692116,"about_ca_system_score_codex":0.00060503883,"about_ca_system_score_gemma":0.00081477803,"threshold_uncertainty_score":0.015954554},"labels":[],"label_agreement":null},{"id":"W4385215457","doi":"10.1016/s2665-9913(23)00157-1","title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Open label; Pilot trial; Medicine; Action (physics); Mechanism (biology); Disease; Physical therapy; Physical medicine and rehabilitation; Psychology; Clinical trial; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.1276448470735835,"score_gpt":0.36163248715823204,"score_spread":0.23398764008464853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385215457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992446,0.003112064,0.0006491451,0.00040766285,0.00017030779,0.0018018554,0.00049907976,0.000057904697,0.0008559886],"genre_scores_gemma":[0.9908529,0.0018814882,0.0017298067,0.00075962656,0.00026747282,0.0020442419,0.0009813587,0.00002529313,0.001457787],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99906296,0.000526515,0.00004690513,0.00012102087,0.000073752235,0.00016884004],"domain_scores_gemma":[0.99870825,0.00040166356,0.00024966025,0.00010843747,0.00009383059,0.00043815188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032637862,0.0019361096,0.0034021402,0.00037846612,0.00041843354,0.001325562,0.000988675,0.0024415802,0.0034673987],"category_scores_gemma":[0.0020261016,0.0006362515,0.0021440184,0.0003314426,0.0014104021,0.0014716751,0.00041893902,0.004039585,0.00063072087],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9291345,0.0188203,0.00094474445,0.0005771022,0.0008091639,0.00009044243,0.00011631594,0.00068453414,0.011808716,0.00014089793,0.0006242099,0.036249172],"study_design_scores_gemma":[0.6858307,0.30845267,0.0028407443,0.00003281062,0.00029744877,0.0000838429,0.000026784663,0.0006135858,0.0010897674,0.0001286477,0.0005799455,0.000023028027],"about_ca_topic_score_codex":0.00049654045,"about_ca_topic_score_gemma":0.00085693336,"teacher_disagreement_score":0.0034673987,"about_ca_system_score_codex":0.000724196,"about_ca_system_score_gemma":0.0012505221,"threshold_uncertainty_score":0.01726073},"labels":[],"label_agreement":null},{"id":"W4386042200","doi":"10.1016/s2665-9913(23)00163-7","title":"Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1729,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"International Door Association; Faculty of Medicine and Health, University of Sydney; University of Health and Allied Sciences; Rede de Química e Tecnologia; National Center of Neurology and Psychiatry; Madda Walabu University; University of South Carolina; Universitetet i Bergen; Laboratório Associado para a Química Verde; University of Peradeniya; Bahir Dar University; Xiamen University; University of Toronto; Universidade Federal de Santa Catarina; National Health and Medical Research Council; Universidade de São Paulo; Shiraz University of Medical Sciences; Research Management Centre, International Islamic University Malaysia; Menzies Institute for Medical Research; Shiraz University; King Abdulaziz University; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministero della Salute; Islamic Azad University; Kasturba Medical College, Manipal; Bill and Melinda Gates Foundation; Curtin University of Technology; Russian Academy of Sciences; Universiteit Maastricht; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Royal College of Surgeons in Ireland; Public Health Foundation of India; Medical Research Council; Indian Council of Medical Research; National Institute for Health and Care Research; Høgskulen på Vestlandet; Saveetha Dental College; University of Tasmania; Monash University; Pirogov Russian National Research Medical University; Manipal Academy of Higher Education; University of Southern California; Fondation de la recherche en santé du Nouveau-Brunswick; Babol University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Iran University of Medical Sciences; U.S. Department of Veterans Affairs; International Association for the Study of Pain; Kaiser Permanente","keywords":"Burden of disease; Disease; Medicine; Disease burden; Osteoarthritis; Internal medicine; Alternative medicine; Pathology","score_opus":0.0332069495262476,"score_gpt":0.32134294046905926,"score_spread":0.28813599094281167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386042200","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032468162,0.88686794,0.008229704,0.0029349385,0.00061092764,0.0007044215,0.066955015,0.00021148036,0.0010173755],"genre_scores_gemma":[0.4442086,0.479554,0.020638196,0.002787258,0.00055100676,0.0036751323,0.0476034,0.00015164091,0.0008307949],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99125504,0.004715084,0.0015270534,0.000993795,0.0011884926,0.0003204314],"domain_scores_gemma":[0.9931767,0.0032005645,0.0013957837,0.0003811696,0.0016646851,0.00018108758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017288482,0.0017460812,0.0054825754,0.007774163,0.00035193883,0.0015104825,0.0013122051,0.001351272,0.0022296463],"category_scores_gemma":[0.022602407,0.0013515841,0.027211051,0.010210013,0.0004420575,0.0010779138,0.001539663,0.0014040279,0.00046848366],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003485047,0.00005847545,0.13218671,0.23310472,0.4986469,0.00054427923,0.00056020945,0.017224576,0.0006412688,0.0029202432,0.035852477,0.07477512],"study_design_scores_gemma":[0.0027318418,0.0005484923,0.15921275,0.088310026,0.69201213,0.000754731,0.00054916384,0.013773519,0.0004798717,0.0043438068,0.03699718,0.00028642887],"about_ca_topic_score_codex":0.063417956,"about_ca_topic_score_gemma":0.09957226,"teacher_disagreement_score":0.063417956,"about_ca_system_score_codex":0.0026043542,"about_ca_system_score_gemma":0.0067411927,"threshold_uncertainty_score":0.12609768},"labels":[],"label_agreement":null},{"id":"W4386042284","doi":"10.1016/s2665-9913(23)00120-0","title":"Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research; University of Toronto","funders":"Eli Lilly and Company","keywords":"Secukinumab; Medicine; Placebo; Psoriasis; Psoriasis Area and Severity Index; Clinical trial; Internal medicine; Plaque psoriasis; Adverse effect; Surgery; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.05122242741578401,"score_gpt":0.3182541849661377,"score_spread":0.2670317575503537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386042284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218047,0.00411537,0.00048689265,0.00034290517,0.0004848659,0.0011066359,0.00035662905,0.00010356464,0.00082269503],"genre_scores_gemma":[0.99282163,0.0018077114,0.0009009215,0.00058980373,0.00045615222,0.00135913,0.0003986654,0.00003157716,0.0016343176],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987577,0.0007067816,0.00008323471,0.00018518261,0.00009604041,0.0001709557],"domain_scores_gemma":[0.9987446,0.00043299797,0.00024643322,0.00011782897,0.000071386705,0.0003866021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002636423,0.0019783343,0.005291281,0.0005643156,0.0005646392,0.0013115036,0.0012716783,0.002611701,0.0050257733],"category_scores_gemma":[0.002088139,0.0012737712,0.0026740625,0.00049935223,0.001955615,0.0017158998,0.00052219746,0.003633274,0.0011554643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98994935,0.00290918,0.000163415,0.00021207455,0.00037103362,0.000014404355,0.000028714585,0.00010816771,0.0018203194,0.000030037003,0.00013811067,0.004255285],"study_design_scores_gemma":[0.8966991,0.0999316,0.001917939,0.000019597166,0.00037781213,0.000024085715,0.000020153715,0.00031648623,0.00036273454,0.0000974235,0.0002119625,0.000021175287],"about_ca_topic_score_codex":0.00067924935,"about_ca_topic_score_gemma":0.00096332293,"teacher_disagreement_score":0.005291281,"about_ca_system_score_codex":0.0006918372,"about_ca_system_score_gemma":0.0009630018,"threshold_uncertainty_score":0.016812861},"labels":[],"label_agreement":null},{"id":"W4386042480","doi":"10.1016/s2665-9913(23)00215-1","title":"Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novo Nordisk Fonden","keywords":"Hydroxychloroquine; Pregnancy; Medicine; Period (music); Postpartum period; Obstetrics; Pediatrics; Internal medicine; Coronavirus disease 2019 (COVID-19); Philosophy","score_opus":0.03587238227288032,"score_gpt":0.2835819664271574,"score_spread":0.24770958415427707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386042480","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068495737,0.0061536096,0.000119253054,0.9324199,0.0563461,0.000012250401,0.00051674363,0.00003868742,0.0037084955],"genre_scores_gemma":[0.007127776,0.0034569427,0.00018345515,0.9145834,0.071835086,0.000038478647,0.00017652236,0.000048564856,0.0025498406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940392,0.0016829161,0.00090721034,0.0009421457,0.0015969004,0.0008316528],"domain_scores_gemma":[0.9660926,0.020929635,0.0048434637,0.0010102195,0.0044285995,0.0026954361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007015243,0.0011328015,0.0016915255,0.0011944751,0.0019448244,0.0025228816,0.0031605721,0.039196964,0.007652892],"category_scores_gemma":[0.03415138,0.0008800291,0.002401515,0.0020342728,0.0039274096,0.0025273075,0.002146277,0.03301056,0.0041570314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039524844,0.00003817027,0.002495955,0.0007559653,0.00015725107,0.0010214124,0.00047088994,0.000114123286,0.0005300941,0.0029913753,0.97914505,0.011884358],"study_design_scores_gemma":[0.00040350627,0.00025478448,0.017012868,0.0028811176,0.00046496643,0.0009787051,0.0009558455,0.0001862545,0.0006370371,0.0026073537,0.9734821,0.00013540305],"about_ca_topic_score_codex":0.013074679,"about_ca_topic_score_gemma":0.012300351,"teacher_disagreement_score":0.039196964,"about_ca_system_score_codex":0.0028410815,"about_ca_system_score_gemma":0.0042654914,"threshold_uncertainty_score":0.037100613},"labels":[],"label_agreement":null},{"id":"W4386631074","doi":"10.1016/s2665-9913(23)00209-6","title":"Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Johnson and Johnson; Janssen Research and Development; Sierra Oncology; Union Chimique Belge; GlaxoSmithKline; AstraZeneca Australia; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Prednisolone; Internal medicine; Tapering; Azathioprine; Cohort; Connective tissue disease; Disease; Autoimmune disease","score_opus":0.022718039585149005,"score_gpt":0.3168484744027069,"score_spread":0.2941304348175579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386631074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987826,0.000573152,0.000036576836,0.00008046371,0.00001768553,0.000007994608,0.00035359003,0.0000023034725,0.00014559401],"genre_scores_gemma":[0.9991817,0.00013101703,0.00004525846,0.000051198644,0.00002657248,0.0000108614495,0.00042742715,0.0000031292254,0.00012297963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980596,0.0007754136,0.00017843241,0.00047832256,0.0001705884,0.0003375527],"domain_scores_gemma":[0.9953596,0.0008106941,0.0020919554,0.00073472864,0.0002598077,0.00074324757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029217491,0.0008138081,0.0011628247,0.00054734724,0.0007787458,0.0014581978,0.0012175716,0.0016343467,0.0012095494],"category_scores_gemma":[0.0048876037,0.0007236997,0.0025849051,0.0012860157,0.0005841528,0.0012372436,0.001030898,0.0021806713,0.00020395932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024691378,0.00010838593,0.99468035,0.000021496558,0.0012344429,0.000099797435,0.00010124574,0.00007128645,0.00024685057,0.000016554179,0.0001301831,0.00082020817],"study_design_scores_gemma":[0.00009894595,0.00032842308,0.99859244,0.000007974476,0.00048442272,0.00010195315,0.00012469149,0.0001257523,0.000020542619,0.000016522175,0.000087868655,0.000010590349],"about_ca_topic_score_codex":0.009117793,"about_ca_topic_score_gemma":0.009009915,"teacher_disagreement_score":0.009117793,"about_ca_system_score_codex":0.00066787336,"about_ca_system_score_gemma":0.00053192425,"threshold_uncertainty_score":0.018129408},"labels":[],"label_agreement":null},{"id":"W4387890091","doi":"10.1016/s2665-9913(23)00241-2","title":"Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; University College London Hospitals Biomedical Research Centre; Genentech; Nordic Pharma Group; Ono Pharmaceutical; National Institute for Health and Care Research; Arthritis Society; British Society for Rheumatology; Argenx; Medical Research Council; Versus Arthritis; Celgene; Biogen; Gilead Sciences; Sanofi; Roche; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Etanercept; Rituximab; Tocilizumab; Internal medicine; Rheumatism; Rheumatology; Population; Clinical trial; Surgery; Lymphoma","score_opus":0.0797515025468418,"score_gpt":0.3473685665879094,"score_spread":0.26761706404106755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387890091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643827,0.012930353,0.0017759333,0.001064825,0.00066722924,0.01633497,0.0013449684,0.00008803047,0.0014109666],"genre_scores_gemma":[0.9592056,0.0048358636,0.0058576483,0.0021338894,0.00086611253,0.024173453,0.0014358782,0.0000301358,0.0014614265],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99069136,0.006917528,0.00074345217,0.00083273934,0.00041042842,0.00040449717],"domain_scores_gemma":[0.99337476,0.0024318586,0.0020723268,0.00068014435,0.0005112047,0.00092960184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012160011,0.0027271968,0.004779244,0.0007891486,0.0008357148,0.0016078883,0.0014252253,0.0043042325,0.00399279],"category_scores_gemma":[0.009557188,0.0011626795,0.0053021237,0.0009925247,0.002353365,0.002264195,0.0012593006,0.0032366337,0.000734673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98228365,0.0037765235,0.0007602158,0.0008870168,0.0021934675,0.000024319714,0.00007589557,0.0002230263,0.0014338312,0.0001099843,0.00022155383,0.008010561],"study_design_scores_gemma":[0.93722564,0.05991874,0.0011856507,0.00006488171,0.0007403296,0.000029406909,0.000019494366,0.00012822526,0.00017727907,0.00018386699,0.00031084198,0.0000156942],"about_ca_topic_score_codex":0.00061622023,"about_ca_topic_score_gemma":0.0013679288,"teacher_disagreement_score":0.012160011,"about_ca_system_score_codex":0.0012589013,"about_ca_system_score_gemma":0.0019064585,"threshold_uncertainty_score":0.06430912},"labels":[],"label_agreement":null},{"id":"W4387890110","doi":"10.1016/s2665-9913(23)00238-2","title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital; Western University","funders":"Merck Sharp and Dohme; Bayer","keywords":"Riociguat; Placebo; Medicine; Adverse effect; Internal medicine; Pulmonary hypertension; Chronic thromboembolic pulmonary hypertension; Pathology","score_opus":0.04331733228793644,"score_gpt":0.2998598101575052,"score_spread":0.25654247786956874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387890110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96650577,0.023880802,0.00090886716,0.0013023036,0.0010990526,0.0022398937,0.0009999346,0.00031911707,0.0027442663],"genre_scores_gemma":[0.98309916,0.0066132345,0.0015335996,0.0017930133,0.0006764894,0.0022397316,0.0012005678,0.000038333113,0.0028059403],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99900407,0.0004875291,0.000045692126,0.00019208633,0.00007447353,0.00019614276],"domain_scores_gemma":[0.9991404,0.00031603817,0.00014129507,0.00007483571,0.00006865176,0.00025883366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021813926,0.002255496,0.005219346,0.00044643576,0.00041648914,0.0013614265,0.0010894025,0.002638125,0.0048109465],"category_scores_gemma":[0.0016978646,0.00063349964,0.0026838789,0.0004684167,0.0014316835,0.001467474,0.0004544036,0.00418817,0.001063336],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97416866,0.0029314267,0.00045411158,0.0009869662,0.0010204448,0.00006293808,0.000057428,0.00018710304,0.0024818482,0.00009558248,0.000719287,0.016834209],"study_design_scores_gemma":[0.9630647,0.03429944,0.0013892764,0.00004220724,0.00040442182,0.000033392847,0.000021886011,0.00013354309,0.00018702995,0.00006875626,0.0003438523,0.000011448093],"about_ca_topic_score_codex":0.0010753348,"about_ca_topic_score_gemma":0.0022339127,"teacher_disagreement_score":0.005219346,"about_ca_system_score_codex":0.0007250192,"about_ca_system_score_gemma":0.00076869497,"threshold_uncertainty_score":0.016094267},"labels":[],"label_agreement":null},{"id":"W4387890132","doi":"10.1016/s2665-9913(23)00232-1","title":"Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Human Resource Development; Faculty of Medicine and Health, University of Sydney; Yonsei University College of Medicine; Russian Academy of Sciences; National Health and Medical Research Council; Medical Research Council; Department of Anthropology, McMaster University; University of Health and Allied Sciences; Pirogov Russian National Research Medical University; Rajshahi University; Menzies Institute for Medical Research; Madda Walabu University; Rede de Química e Tecnologia; National Center of Neurology and Psychiatry; University of Social Welfare and Rehabilitation Sciences; University of Peradeniya; Secretaria Nacional de Ciencia y Tecnología; Xiamen University; Bahir Dar University; Universidade de São Paulo; Panjab University; Shiraz University; Public Health Foundation of India; Royal College of Surgeons in Ireland; Mashhad University of Medical Sciences; Naresuan University; Science and Technology Development Fund; Hong Kong Polytechnic University; Directorate for Biological Sciences; Mansoura University; King Abdulaziz University; Tampereen Yliopisto; St. George's, University of London; Ministero della Salute; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Islamic Azad University; Kyung Hee University; University of Southern California; Yonsei University; Shiraz University of Medical Sciences; University Grants Committee; Academy of Scientific Research and Technology; Monash University; Indian Council of Medical Research; University of California, Irvine; University of Leeds; National Institute for Health and Care Research; Høgskulen på Vestlandet; Saveetha Dental College; University of Tasmania; Bill and Melinda Gates Foundation; Zahedan University of Medical Sciences; Curtin University of Technology; Universidade Federal de Santa Catarina; University of Toronto; Macquarie University; Kasturba Medical College, Manipal; Health Research Council of New Zealand; Universiteit Maastricht; University of New South Wales; Yale University; U.S. Department of Veterans Affairs; Babol University of Medical Sciences; University of Glasgow; Tehran University of Medical Sciences and Health Services; Laboratório Associado para a Química Verde; Universitetet i Bergen; University of South Carolina; Shaqra University; Iran University of Medical Sciences; Fondation de la recherche en santé du Nouveau-Brunswick; University of Otago; British Heart Foundation; Khalifa University of Science, Technology and Research; International Association for the Study of Pain; Case Western Reserve University; King Abdulaziz City for Science and Technology; Cleveland Clinic Foundation; Kaiser Permanente","keywords":"Burden of disease; Disease burden; Medicine; Disease; Environmental health; Pathology","score_opus":0.016747840406892738,"score_gpt":0.32333382966357516,"score_spread":0.3065859892566824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387890132","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038454503,0.87434787,0.0041238526,0.0031975708,0.0004591432,0.000313454,0.07762458,0.0001349086,0.0013441435],"genre_scores_gemma":[0.38762376,0.5597162,0.009313611,0.0024461586,0.0005359268,0.0014344634,0.038240198,0.00006853992,0.0006211345],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99519676,0.002044931,0.0010032598,0.000719035,0.00083495624,0.0002010383],"domain_scores_gemma":[0.9943885,0.0020459103,0.00143364,0.00026325218,0.0017186283,0.00015007185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010904318,0.0013117308,0.0033823443,0.0057323934,0.00028562275,0.0012605367,0.00088857044,0.00098767,0.0016019341],"category_scores_gemma":[0.0144624775,0.00094435085,0.015126594,0.009985493,0.00041403656,0.00084406073,0.0011373135,0.0010248311,0.00038497205],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025578071,0.00006500295,0.30714685,0.21377543,0.28201967,0.0005732807,0.0006699882,0.01710519,0.0007695017,0.0021598444,0.051716093,0.121441394],"study_design_scores_gemma":[0.0017191446,0.0005104263,0.40748683,0.115608975,0.40872213,0.0012222626,0.0008066095,0.009246865,0.00061960134,0.0038008501,0.04998123,0.00027510198],"about_ca_topic_score_codex":0.048393533,"about_ca_topic_score_gemma":0.07776003,"teacher_disagreement_score":0.048393533,"about_ca_system_score_codex":0.0021402398,"about_ca_system_score_gemma":0.0059033716,"threshold_uncertainty_score":0.09622371},"labels":[],"label_agreement":null},{"id":"W4388656955","doi":"10.1016/s2665-9913(23)00264-3","title":"Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"Canadian Rheumatology Association","keywords":"Psoriatic arthritis; Medicine; Clinical trial; Meta-analysis; Arthritis; Disease; Randomized controlled trial; Physical therapy; Alternative medicine; Internal medicine; Pathology","score_opus":0.06830442214830293,"score_gpt":0.3603085573008006,"score_spread":0.2920041351524977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388656955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016039148,0.9817878,0.0008449454,0.00017182958,0.00027526327,0.00026847815,0.00034755084,0.000033968263,0.00023101503],"genre_scores_gemma":[0.62862647,0.36229417,0.0041790847,0.001801695,0.00059981004,0.0011869478,0.0007834293,0.00007466105,0.00045364158],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96778315,0.016511979,0.009576859,0.003163376,0.002319516,0.00064506894],"domain_scores_gemma":[0.94832075,0.0403363,0.0075105457,0.0022174849,0.0012016596,0.00041323877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029724592,0.0024545186,0.018492023,0.0034762414,0.0006466167,0.004011758,0.0022006084,0.003378505,0.0030805347],"category_scores_gemma":[0.061641876,0.002027065,0.043211617,0.0046898797,0.0015232706,0.0025683967,0.0020484193,0.002815696,0.000258158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00673769,0.0000363846,0.0055062007,0.098696694,0.8825879,0.000060528248,0.000083933264,0.00027709568,0.000159674,0.00008924405,0.00022519364,0.0055395225],"study_design_scores_gemma":[0.0028044528,0.00030781035,0.0054114936,0.0042790207,0.9862364,0.00004487214,0.00004358104,0.00013716817,0.00006350111,0.00018342689,0.00046504333,0.00002324916],"about_ca_topic_score_codex":0.0042308583,"about_ca_topic_score_gemma":0.010261099,"teacher_disagreement_score":0.029724592,"about_ca_system_score_codex":0.0023217062,"about_ca_system_score_gemma":0.0023307886,"threshold_uncertainty_score":0.15720057},"labels":[],"label_agreement":null},{"id":"W4388693978","doi":"10.1016/s2665-9913(23)00301-6","title":"Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron era","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Vaccination; Medicine; Hindsight bias; Immunology; Booster (rocketry); Population; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Disease; Environmental health; Internal medicine; Infectious disease (medical specialty)","score_opus":0.019643280953077488,"score_gpt":0.30098040926800723,"score_spread":0.28133712831492974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388693978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382716,0.0026643572,0.000182482,0.0009968611,0.00024229525,0.00012104076,0.00022327268,0.000042241834,0.0017001629],"genre_scores_gemma":[0.9976841,0.00047338216,0.00026231955,0.0004912571,0.00010667715,0.000093301016,0.000117174335,0.0000046708333,0.0007670474],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992275,0.00031682747,0.000039879935,0.00014106139,0.000076895085,0.00019768048],"domain_scores_gemma":[0.99873596,0.00048964313,0.00019355478,0.00010318039,0.00009190209,0.0003857116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011002157,0.00044923986,0.0012900513,0.00029734464,0.00049028685,0.0005674985,0.0003437852,0.0014149023,0.0041987076],"category_scores_gemma":[0.0028454915,0.00020554241,0.0009893916,0.00016746581,0.00041893407,0.0006013847,0.0003103601,0.0012794829,0.00042547108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51314765,0.022331804,0.08610631,0.00079343125,0.0013760314,0.00047339482,0.00082976563,0.0015267156,0.020252239,0.0005913188,0.0041082157,0.34846318],"study_design_scores_gemma":[0.05667987,0.5515485,0.36740887,0.0006053748,0.002992814,0.0006524155,0.0013816868,0.0030124923,0.008331878,0.0008434807,0.006449407,0.00009319073],"about_ca_topic_score_codex":0.0030195913,"about_ca_topic_score_gemma":0.003775037,"teacher_disagreement_score":0.0041987076,"about_ca_system_score_codex":0.00081120396,"about_ca_system_score_gemma":0.00095721456,"threshold_uncertainty_score":0.014046073},"labels":[],"label_agreement":null},{"id":"W4389327761","doi":"10.1016/s2665-9913(23)00297-7","title":"Is low-dose naltrexone for fibromyalgia another treatment disappointment?","year":2023,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fibromyalgia; Pregabalin; Duloxetine; Medicine; Milnacipran; Placebo; Naltrexone; Opioid; Physical therapy; Psychiatry; Internal medicine; Alternative medicine; Antidepressant; Anxiety","score_opus":0.07303740965453133,"score_gpt":0.3561814548580426,"score_spread":0.2831440452035113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389327761","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057496326,0.20193498,0.0006138664,0.7572732,0.023175413,0.00003248336,0.00033061314,0.00007992861,0.010810011],"genre_scores_gemma":[0.10234453,0.18415497,0.0022901387,0.6410899,0.060610253,0.000100187666,0.00044799093,0.000086834785,0.008875163],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966545,0.0014519079,0.0004941894,0.00027271203,0.0008262566,0.00030045622],"domain_scores_gemma":[0.9795476,0.012703049,0.0020039838,0.00072323345,0.00308335,0.0019387172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00931876,0.00035680595,0.0019775343,0.0005103854,0.0010347792,0.0020617368,0.0012470745,0.005765632,0.008030152],"category_scores_gemma":[0.024037462,0.00026260913,0.0016681562,0.00059528364,0.0023396083,0.002759988,0.0007104313,0.010781708,0.002987785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062518334,0.0003998257,0.0034849746,0.004253982,0.0011510736,0.0011102923,0.000314563,0.00034273512,0.0033801121,0.010399546,0.2731061,0.6958049],"study_design_scores_gemma":[0.006886553,0.0053634113,0.019903783,0.0072616795,0.0016239334,0.0033822642,0.0013693031,0.00038488614,0.0010895651,0.018412028,0.9340309,0.00029163487],"about_ca_topic_score_codex":0.0018214786,"about_ca_topic_score_gemma":0.00741599,"teacher_disagreement_score":0.00931876,"about_ca_system_score_codex":0.0015614108,"about_ca_system_score_gemma":0.002410973,"threshold_uncertainty_score":0.04928285},"labels":[],"label_agreement":null},{"id":"W4396749278","doi":"10.1016/s2665-9913(24)00064-x","title":"Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Instituto de Salud Carlos III; Medical Research Council; National Institute for Health and Care Research; Ministerio de Ciencia, Innovación y Universidades","keywords":"Genome-wide association study; Giant cell arteritis; Genetic association; Vasculitis; Biology; Pathogenesis; Genetics; Disease; Medicine; Gene; Immunology; Pathology; Genotype; Single-nucleotide polymorphism","score_opus":0.01397760762467984,"score_gpt":0.2580992342308933,"score_spread":0.24412162660621348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396749278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875536,0.008162855,0.0021140433,0.00039786848,0.00006388906,0.000030503772,0.0011095655,0.000050515155,0.0005171573],"genre_scores_gemma":[0.997459,0.00095828075,0.00081034267,0.000095810574,0.00004169093,0.000022510569,0.0004812701,0.00001091231,0.000120199744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840766,0.0004938087,0.00017204667,0.000614297,0.00018285007,0.00012936308],"domain_scores_gemma":[0.9976063,0.0012952484,0.00048101446,0.00029012523,0.00015376872,0.00017356944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019110898,0.0008211507,0.0010446591,0.0012958236,0.0006050028,0.0010014833,0.0006784726,0.0011732058,0.0021975802],"category_scores_gemma":[0.0038794023,0.00040151872,0.0028728805,0.0031630325,0.0005180869,0.0003464854,0.0008406646,0.0009797637,0.00018368682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032173786,0.00008058099,0.954679,0.00042642388,0.023122584,0.0018768477,0.00022203893,0.0011872544,0.0059067775,0.00027321777,0.000690698,0.008317146],"study_design_scores_gemma":[0.00034812908,0.00023696186,0.977729,0.00008999378,0.015365428,0.0016642851,0.00014231895,0.0023126646,0.00041211722,0.0006088541,0.0010613779,0.000028875134],"about_ca_topic_score_codex":0.0045882454,"about_ca_topic_score_gemma":0.0049551916,"teacher_disagreement_score":0.0045882454,"about_ca_system_score_codex":0.0002353534,"about_ca_system_score_gemma":0.0003602698,"threshold_uncertainty_score":0.010106921},"labels":[],"label_agreement":null},{"id":"W4399762352","doi":"10.1016/s2665-9913(24)00165-6","title":"Engagement of people with lived experience in studies published in high-impact rheumatology journals: a meta-research review","year":2024,"lang":"en","type":"review","venue":"The Lancet Rheumatology","topic":"Empathy and Medical Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; St. Joseph’s Healthcare Hamilton; McGill University; McMaster University; Jewish General Hospital","funders":"","keywords":"Rheumatology; Internal medicine; Medicine; Meta-analysis; Psychology","score_opus":0.5025936091810373,"score_gpt":0.5536662840848823,"score_spread":0.05107267490384493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399762352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019339484,0.99723804,0.0001686096,0.00015095728,0.00011936467,0.00009835455,0.00013522203,0.0000048111665,0.00015074696],"genre_scores_gemma":[0.1016958,0.8939991,0.0014086384,0.0014402758,0.00035858992,0.00047600747,0.00038846824,0.000025543244,0.000207687],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97525406,0.010245742,0.0082471045,0.0025747218,0.002958119,0.0007202832],"domain_scores_gemma":[0.893402,0.088645235,0.012111451,0.0020658658,0.0031229167,0.0006524693],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02597815,0.0022924175,0.013334436,0.0074604666,0.0008335682,0.006209929,0.0023465257,0.0038296704,0.007215316],"category_scores_gemma":[0.09312969,0.0016109655,0.018580016,0.009048796,0.0014524859,0.0040082633,0.0037507054,0.0026489808,0.00050996157],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012570736,0.000059248097,0.008661256,0.6728426,0.27834874,0.00012796295,0.00057178165,0.00010905221,0.00019836951,0.00028685818,0.00096656056,0.03657042],"study_design_scores_gemma":[0.000751348,0.00027668927,0.01871963,0.238165,0.73172945,0.00028415862,0.00088838715,0.0000893927,0.00018917955,0.00073223235,0.008085228,0.00008919598],"about_ca_topic_score_codex":0.0047518252,"about_ca_topic_score_gemma":0.01693909,"teacher_disagreement_score":0.97402185,"about_ca_system_score_codex":0.002443459,"about_ca_system_score_gemma":0.0047170594,"threshold_uncertainty_score":0.13738722},"labels":[],"label_agreement":null},{"id":"W4399993508","doi":"10.1016/s2665-9913(24)00167-x","title":"Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Certolizumab pegol; Axial spondyloarthritis; Rheumatoid arthritis; Arthritis; Tumor necrosis factor alpha; Internal medicine; Adalimumab; Spondylitis; Immunology; Oncology; Sacroiliitis","score_opus":0.05056455840809632,"score_gpt":0.3340036590250223,"score_spread":0.283439100616926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399993508","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037562372,0.54116553,0.030840319,0.2693677,0.1371364,0.00553027,0.002937337,0.00076647155,0.008499701],"genre_scores_gemma":[0.054997757,0.23295848,0.09909959,0.4625795,0.12440128,0.012271228,0.0029710042,0.0011670904,0.009554122],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.72440714,0.18234873,0.04005874,0.011234337,0.03635445,0.0055965884],"domain_scores_gemma":[0.2657823,0.61433136,0.032308016,0.025980888,0.04804393,0.013553546],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.40564403,0.0062308423,0.02299339,0.0025016419,0.00329501,0.019144548,0.012814926,0.04779243,0.03025253],"category_scores_gemma":[0.51122993,0.005337909,0.022176243,0.002216972,0.018083906,0.03438478,0.008858581,0.046094015,0.013839379],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08842807,0.0022342384,0.0024294374,0.19719648,0.03988986,0.0017551127,0.0018549843,0.0012283326,0.005720741,0.06546463,0.23927754,0.3545206],"study_design_scores_gemma":[0.06601771,0.018412212,0.00419647,0.12708558,0.026754022,0.0011580931,0.0010302932,0.0011666826,0.0031838573,0.105099946,0.6450649,0.0008303026],"about_ca_topic_score_codex":0.00169593,"about_ca_topic_score_gemma":0.0028639336,"teacher_disagreement_score":0.59435594,"about_ca_system_score_codex":0.00679833,"about_ca_system_score_gemma":0.01738608,"threshold_uncertainty_score":0.73294675},"labels":[],"label_agreement":null},{"id":"W4400027147","doi":"10.1016/s2665-9913(24)00166-8","title":"Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Telehealth; Coronavirus disease 2019 (COVID-19); Pandemic; Cross-sectional study; 2019-20 coronavirus outbreak; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Telemedicine; Psychology; Health care; Virology; Political science; Disease; Outbreak; Internal medicine","score_opus":0.04092975221929479,"score_gpt":0.32030457946386665,"score_spread":0.27937482724457186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400027147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989668,0.00011849566,0.000024717127,0.00016909675,0.000007741898,0.000016639857,0.00020990471,8.044601e-7,0.00048588176],"genre_scores_gemma":[0.9990978,0.0001507564,0.000044157045,0.00025417967,0.00001210338,0.000027142714,0.00014070279,0.0000017186851,0.00027140602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989188,0.00036417827,0.0001238684,0.00012812701,0.00014420593,0.0003208423],"domain_scores_gemma":[0.99592185,0.0008802605,0.0015573621,0.00013698195,0.0003588147,0.0011447436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013691566,0.00019680765,0.0004089676,0.0006773353,0.0016507509,0.0020560268,0.00038630326,0.0014546799,0.0031397643],"category_scores_gemma":[0.0052450406,0.0004925538,0.00086906966,0.0010195363,0.0007905542,0.0020329703,0.0017918828,0.0024101096,0.00043698496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028772608,0.00065906433,0.9704949,0.00009426698,0.00013648513,0.00029929227,0.02321484,0.000047599413,0.000251399,0.00007109167,0.0004211516,0.004022096],"study_design_scores_gemma":[0.000016309863,0.00055705936,0.93939716,0.000069853806,0.000048760237,0.00027217966,0.058764495,0.00008381498,0.000046141144,0.0000437101,0.0006727084,0.000027881351],"about_ca_topic_score_codex":0.020027148,"about_ca_topic_score_gemma":0.024649998,"teacher_disagreement_score":0.020027148,"about_ca_system_score_codex":0.0007678958,"about_ca_system_score_gemma":0.00083366357,"threshold_uncertainty_score":0.039821208},"labels":[],"label_agreement":null},{"id":"W4400267589","doi":"10.1016/s2665-9913(24)00161-9","title":"Painful scalp nodules in SAPHO syndrome","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"SAPHO syndrome; Scalp; Medicine; Hyperostosis; Anatomy; Pustulosis; Surgery; Osteitis","score_opus":0.029958943265633236,"score_gpt":0.32660558382564003,"score_spread":0.2966466405600068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400267589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8592414,0.059877787,0.0012594222,0.014690846,0.0010982628,0.00010011729,0.00066166674,0.00025092956,0.06281968],"genre_scores_gemma":[0.9895287,0.00598338,0.00030865212,0.0010513931,0.0015696645,0.000008552094,0.00011465526,0.000016639475,0.0014182319],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996606,0.0000619374,0.000031265106,0.000046043595,0.0000854318,0.000114771545],"domain_scores_gemma":[0.9988599,0.0005555246,0.00019611351,0.00006511504,0.0001010472,0.00022223675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035807904,0.0008451142,0.00070327276,0.0011029042,0.00036580669,0.0010080708,0.0005485624,0.0027789448,0.006211874],"category_scores_gemma":[0.002664969,0.0003990124,0.00036728638,0.0009709617,0.0011094417,0.000826175,0.00050158123,0.0011034028,0.00078586733],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015953489,0.00014074254,0.13499393,0.0012061027,0.00020476864,0.74582905,0.00062158605,0.00051646197,0.014984365,0.003368958,0.018119453,0.078419216],"study_design_scores_gemma":[0.00032750206,0.00020496841,0.19766098,0.0002979277,0.00017188273,0.79008746,0.00081132795,0.00077467307,0.00073153235,0.0037574447,0.005128682,0.0000456825],"about_ca_topic_score_codex":0.0024147457,"about_ca_topic_score_gemma":0.0017868596,"teacher_disagreement_score":0.006211874,"about_ca_system_score_codex":0.00035743325,"about_ca_system_score_gemma":0.00036092897,"threshold_uncertainty_score":0.020780802},"labels":[],"label_agreement":null},{"id":"W4400439918","doi":"10.1016/s2665-9913(24)00117-6","title":"Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Zayed University; Universidade do Porto; Shahid Beheshti University of Medical Sciences; Uniwersytet Łódzki; Universidade de São Paulo; Kermanshah University of Medical Sciences; Monash University; Jimma University; Ahvaz Jundishapur University of Medical Sciences; Universiti Sains Malaysia; National Institute of Pharmaceutical Education and Research, Raebareli; University of Toronto; University of Southern California; University College London; Wollega University; Federation University Australia; Johns Hopkins University; University of Washington; Neyshabur University of Medical Sciences; Isfahan University of Medical Sciences; Harvard University; North Dakota State University; Universitetet i Bergen; National Institute for Health and Care Research; Laboratório Associado para a Química Verde; Rafsanjan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Bill and Melinda Gates Foundation","keywords":"Gout; Medicine; Demography; Disease burden; Population; Burden of disease; Environmental health; Disease; Internal medicine","score_opus":0.02472066148249411,"score_gpt":0.3218261855542545,"score_spread":0.2971055240717604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400439918","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027933948,0.93717235,0.003938997,0.002668097,0.00037710957,0.0002133178,0.026767597,0.00010583034,0.0008228657],"genre_scores_gemma":[0.4032091,0.5637302,0.008782109,0.0025615653,0.00049423845,0.0010540682,0.019711886,0.00007677857,0.00038015054],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948762,0.0025454739,0.00094687834,0.0006894516,0.00073151296,0.00021042011],"domain_scores_gemma":[0.99333185,0.0029845056,0.0015237012,0.00037170624,0.0015962649,0.00019200912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013122062,0.0014176975,0.004239618,0.005734682,0.000331405,0.0012883156,0.00093561265,0.0011356425,0.0014263632],"category_scores_gemma":[0.017170826,0.0010676206,0.015724678,0.007822263,0.00050575804,0.0008623629,0.0013378736,0.0011932884,0.00027887174],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003615798,0.000060332124,0.21688129,0.20769714,0.37852916,0.00051242515,0.0007532313,0.01570631,0.0007728053,0.002519365,0.031713177,0.14123896],"study_design_scores_gemma":[0.002112055,0.0005552107,0.22987576,0.114771105,0.5972603,0.0009315949,0.0006303721,0.009987458,0.00053430407,0.004453464,0.03862763,0.00026082376],"about_ca_topic_score_codex":0.042528793,"about_ca_topic_score_gemma":0.07009807,"teacher_disagreement_score":0.042528793,"about_ca_system_score_codex":0.0021070933,"about_ca_system_score_gemma":0.006149765,"threshold_uncertainty_score":0.08456254},"labels":[],"label_agreement":null},{"id":"W4400673100","doi":"10.1016/s2665-9913(24)00151-6","title":"Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Queensland Health; Bill and Melinda Gates Foundation","keywords":"Health care; Low back pain; Medicine; Business; Gerontology; Physical therapy; Alternative medicine; Economic growth; Economics","score_opus":0.03652050041107422,"score_gpt":0.41207646149129573,"score_spread":0.3755559610802215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400673100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86622334,0.085351534,0.019826572,0.0070683234,0.00016619283,0.0029020738,0.006493927,0.00004699071,0.0119210305],"genre_scores_gemma":[0.97954845,0.00808275,0.010008744,0.00047431438,0.000041245257,0.0010175273,0.00058402034,0.000013263067,0.00022964404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92606866,0.06401742,0.003065681,0.0019221992,0.0026715933,0.0022543967],"domain_scores_gemma":[0.8747972,0.10923046,0.009023712,0.0030517743,0.0030146756,0.0008822613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03826636,0.0008756604,0.0030495508,0.0064751296,0.0010144004,0.0033357593,0.0016529418,0.0024661615,0.0042347996],"category_scores_gemma":[0.08680669,0.00073917134,0.008447081,0.009373062,0.0023984541,0.00246388,0.004853639,0.002364659,0.00017575998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052752276,0.0020353026,0.68854654,0.026919534,0.039313067,0.010690473,0.007478871,0.050663184,0.00066537206,0.04124624,0.005434522,0.12173171],"study_design_scores_gemma":[0.0029795384,0.0073925816,0.7048591,0.02549142,0.0500625,0.015125909,0.028351141,0.09785467,0.0014613367,0.03930399,0.026350347,0.00076752994],"about_ca_topic_score_codex":0.03616657,"about_ca_topic_score_gemma":0.024253365,"teacher_disagreement_score":0.03826636,"about_ca_system_score_codex":0.0051230825,"about_ca_system_score_gemma":0.0029851638,"threshold_uncertainty_score":0.20237428},"labels":[],"label_agreement":null},{"id":"W4401936652","doi":"10.1016/s2665-9913(24)00189-9","title":"The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"Lady Davis Institute for Medical Research; Canadian Institutes of Health Research; Jewish General Hospital; Arthritis Society; Fonds de Recherche du Québec-Société et Culture; Fondation de l'Hôpital général juif; McGill University","keywords":"Scleroderma (fungus); Medicine; Cohort; Systemic scleroderma; Intervention (counseling); Cohort study; Association (psychology); Internal medicine; Dermatology; Physical therapy; Pathology; Psychology; Psychiatry; Disease; Psychotherapist","score_opus":0.010821159574798801,"score_gpt":0.2317359103540185,"score_spread":0.2209147507792197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401936652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986216,0.00013581224,0.00011708941,0.000086814696,0.000026130789,0.00002794661,0.0007381977,0.0000053177305,0.00024099309],"genre_scores_gemma":[0.9988354,0.000083597115,0.00012946958,0.00007223373,0.0000270284,0.000050762996,0.0005109351,0.0000049514606,0.00028561716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987754,0.00043636715,0.00010513434,0.00032723916,0.00014095308,0.00021481057],"domain_scores_gemma":[0.99847347,0.00019413754,0.0005020052,0.00027089674,0.00018494442,0.00037448946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013251789,0.00073092186,0.0008929941,0.0006707387,0.0012610123,0.0013982647,0.0012008534,0.0015835221,0.0016507414],"category_scores_gemma":[0.002429522,0.0010386108,0.0014934536,0.0014935796,0.0005332075,0.001299373,0.0013994391,0.0022548684,0.00038244957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007239434,0.00031794995,0.9967675,0.000023069324,0.0005517004,0.0001009021,0.00024341594,0.000035396904,0.00039006842,0.000027659938,0.00024290137,0.0005754588],"study_design_scores_gemma":[0.000082078965,0.00019982553,0.99877495,0.0000067802644,0.00019095474,0.0000799638,0.0003429687,0.00015128426,0.000029484754,0.000022035263,0.00010877721,0.0000107109],"about_ca_topic_score_codex":0.019077545,"about_ca_topic_score_gemma":0.02007011,"teacher_disagreement_score":0.019077545,"about_ca_system_score_codex":0.00070948986,"about_ca_system_score_gemma":0.00061301223,"threshold_uncertainty_score":0.037932992},"labels":[],"label_agreement":null},{"id":"W4402653539","doi":"10.1016/s2665-9913(24)00272-8","title":"Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Faculty of Medicine, Dalhousie University","keywords":"Vasculitis; Anti-neutrophil cytoplasmic antibody; Medicine; Antibody; Immunology; Internal medicine; Disease","score_opus":0.010054768011720398,"score_gpt":0.27574984634598676,"score_spread":0.26569507833426637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402653539","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28552932,0.65086615,0.0007761701,0.03480331,0.0067609977,0.00012993549,0.00058768416,0.000099652934,0.020446707],"genre_scores_gemma":[0.7311178,0.22779965,0.0017466468,0.025267776,0.009365836,0.00014782566,0.0007312652,0.000014542583,0.0038086039],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975795,0.000065262524,0.00003672954,0.000022417571,0.000059288504,0.00005845121],"domain_scores_gemma":[0.9992687,0.00020668471,0.00020455729,0.000014939685,0.000095903335,0.00020920143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061169616,0.0003332343,0.0009213537,0.00030541822,0.00031564478,0.0005334154,0.0002679701,0.0010836992,0.0019621928],"category_scores_gemma":[0.0024764815,0.00012312859,0.0007624991,0.00025286496,0.00017355308,0.00033134432,0.0004254581,0.0012432395,0.00036424145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007390023,0.0015838394,0.05983021,0.008792754,0.002749862,0.0022726757,0.00067180296,0.0008431944,0.0057976115,0.0009604032,0.112580605,0.79652697],"study_design_scores_gemma":[0.015747372,0.023456227,0.68908435,0.0151713025,0.0059573627,0.0073636496,0.0024124281,0.0019791466,0.0016015616,0.0056517837,0.2314059,0.00016894846],"about_ca_topic_score_codex":0.0031669934,"about_ca_topic_score_gemma":0.008233874,"teacher_disagreement_score":0.0031669934,"about_ca_system_score_codex":0.00047184227,"about_ca_system_score_gemma":0.00060959684,"threshold_uncertainty_score":0.0065641403},"labels":[],"label_agreement":null},{"id":"W4403321167","doi":"10.1016/s2665-9913(24)00223-6","title":"Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Aurinia (Canada)","funders":"Eupraxia Pharmaceuticals; Leeds Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Osteoarthritis; Medicine; Double blind; Physical therapy; Fluticasone propionate; Knee pain; Physical medicine and rehabilitation; Surgery; Alternative medicine; Pathology; Corticosteroid","score_opus":0.021439046602751692,"score_gpt":0.28972693523805376,"score_spread":0.26828788863530206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403321167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693085,0.0036690175,0.000508222,0.0003668274,0.00034468394,0.0062706727,0.0007624784,0.00008191233,0.0010653557],"genre_scores_gemma":[0.9796412,0.0028882108,0.0020905845,0.00077190576,0.00053704606,0.010159974,0.0010213644,0.000029816278,0.0028598907],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854314,0.00074373424,0.000117440526,0.0002672196,0.00013585649,0.0001926345],"domain_scores_gemma":[0.99834025,0.00044603992,0.00048926973,0.0001252648,0.00014724988,0.00045195624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039531216,0.0021968829,0.0031536298,0.00063182757,0.00048051265,0.0011221664,0.0011693498,0.0027610247,0.0057121194],"category_scores_gemma":[0.0028085716,0.0010288581,0.0022025262,0.0004233162,0.0014167913,0.001630031,0.00058148336,0.0024121052,0.0011624852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97314036,0.012576411,0.0003211814,0.00069732056,0.0003747132,0.00003103445,0.000069385016,0.00015933788,0.0034484367,0.00004183907,0.00029651725,0.008843465],"study_design_scores_gemma":[0.86086625,0.13716084,0.0010852787,0.000023471806,0.00019069409,0.000019884486,0.000011015512,0.000116010015,0.00028096107,0.000033475913,0.00020165373,0.000010446557],"about_ca_topic_score_codex":0.00047527338,"about_ca_topic_score_gemma":0.0008116737,"teacher_disagreement_score":0.0057121194,"about_ca_system_score_codex":0.0007090235,"about_ca_system_score_gemma":0.0012355897,"threshold_uncertainty_score":0.02090633},"labels":[],"label_agreement":null},{"id":"W4403589891","doi":"10.1016/s2665-9913(24)00277-7","title":"Explanation for substandard of care comparators in rheumatology randomised trial protocols","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Rheumatology; Randomized controlled trial; Family medicine","score_opus":0.48007978904889936,"score_gpt":0.5910584944676577,"score_spread":0.11097870541875832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403589891","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066190227,0.054502603,0.3421938,0.45168847,0.076740555,0.010672033,0.013692716,0.00408728,0.039803453],"genre_scores_gemma":[0.18541351,0.007037814,0.34321117,0.37677878,0.038093414,0.028202515,0.0026124225,0.0016469539,0.017003419],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.601324,0.29098788,0.063315615,0.014290148,0.026063178,0.004019273],"domain_scores_gemma":[0.25751555,0.6791993,0.028211392,0.02147351,0.011722501,0.001877804],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24417189,0.001730274,0.0041875793,0.0030075281,0.0016337506,0.0068234676,0.0035447062,0.02052926,0.043431256],"category_scores_gemma":[0.606668,0.002295127,0.006969872,0.0032250783,0.005656402,0.0042449054,0.0035234587,0.015041392,0.0068338225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011228503,0.00014034678,0.004799576,0.015826447,0.003264043,0.0013738432,0.0020665713,0.0017480695,0.0007536778,0.342043,0.4420696,0.17468627],"study_design_scores_gemma":[0.025154999,0.00089205924,0.0057298047,0.019516736,0.0022623888,0.0028552278,0.00027185908,0.015512602,0.0021605743,0.5674821,0.35774726,0.0004143372],"about_ca_topic_score_codex":0.0013436492,"about_ca_topic_score_gemma":0.0011133081,"teacher_disagreement_score":0.75582814,"about_ca_system_score_codex":0.0048547075,"about_ca_system_score_gemma":0.005599117,"threshold_uncertainty_score":0.9320706},"labels":[],"label_agreement":null},{"id":"W4403924433","doi":"10.1016/s2665-9913(24)00232-7","title":"Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Amgen","keywords":"Apremilast; Psoriatic arthritis; Medicine; Open label; Dermatology; Physical therapy; Internal medicine; Psoriasis; Clinical trial","score_opus":0.018894660630332245,"score_gpt":0.3293697789352024,"score_spread":0.3104751183048702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403924433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564326,0.0021433684,0.0002009663,0.00019002498,0.000099201774,0.00060585944,0.0003491814,0.000054232416,0.0007139426],"genre_scores_gemma":[0.9945476,0.0011682763,0.0010015093,0.00043104254,0.00024751792,0.0008838343,0.0004847636,0.000013642547,0.001221858],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937624,0.00033764925,0.00003080026,0.000102821075,0.000060287763,0.00009223557],"domain_scores_gemma":[0.99908316,0.00024462378,0.00021938204,0.000088444314,0.000063036256,0.0003013292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015728208,0.0017503218,0.0026502337,0.0003618656,0.00040188213,0.000852667,0.0006867272,0.001478342,0.0026828605],"category_scores_gemma":[0.0013449986,0.00072912767,0.0015759598,0.00027475524,0.0009446137,0.0010252666,0.00041029725,0.0020821146,0.0006456092],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95454216,0.011816909,0.0017125645,0.00053487153,0.0009898319,0.000052493877,0.00007754068,0.00044232555,0.008038736,0.000043671953,0.00039075167,0.02135812],"study_design_scores_gemma":[0.740079,0.24213558,0.015198599,0.000034233708,0.00059084554,0.000102727914,0.00005006253,0.0005975341,0.00071938446,0.000090821144,0.00036296045,0.000038285532],"about_ca_topic_score_codex":0.00069381006,"about_ca_topic_score_gemma":0.001538495,"teacher_disagreement_score":0.0026828605,"about_ca_system_score_codex":0.00044188075,"about_ca_system_score_gemma":0.00071280566,"threshold_uncertainty_score":0.008975089},"labels":[],"label_agreement":null},{"id":"W4404514456","doi":"10.1016/s2665-9913(24)00341-2","title":"Structural racism is a driver of fragmented care and acute care use among people with rheumatic conditions","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Racial and Ethnic Identity Research","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Racism; Acute care; Medicine; Intensive care medicine; Gerontology; Health care; Sociology; Economic growth; Economics; Gender studies","score_opus":0.023210451800128384,"score_gpt":0.3382414401840588,"score_spread":0.3150309883839304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404514456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98583525,0.0015233742,0.00016903949,0.008576117,0.000085538915,0.000017888002,0.00035152474,0.000004253289,0.00343698],"genre_scores_gemma":[0.9985618,0.0004146342,0.00009427846,0.0005288134,0.000060856008,0.000008412706,0.00010597193,0.0000038180956,0.00022156106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646723,0.0012019223,0.0002838286,0.000365323,0.0006136726,0.0010680667],"domain_scores_gemma":[0.9867671,0.0025332558,0.0062048994,0.0007828816,0.0011353074,0.0025766233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019825508,0.00015843123,0.00034360797,0.0011322821,0.0024919428,0.0025724962,0.00093151745,0.0013795833,0.006367138],"category_scores_gemma":[0.015840834,0.00045155073,0.0010054584,0.0024169108,0.0011966451,0.001832997,0.0024961103,0.0035929778,0.00029237015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051855655,0.000104012084,0.9887068,0.000039879185,0.00016409872,0.00007318882,0.0031154964,0.000028229511,0.000049095528,0.00078932144,0.0009904078,0.005887602],"study_design_scores_gemma":[0.000008392848,0.00003469247,0.9885909,0.000119117794,0.00005218517,0.00015169663,0.009011584,0.00014207684,0.000020784053,0.0007041119,0.0011506936,0.000013864772],"about_ca_topic_score_codex":0.0887851,"about_ca_topic_score_gemma":0.11390195,"teacher_disagreement_score":0.0887851,"about_ca_system_score_codex":0.0019046166,"about_ca_system_score_gemma":0.0034507038,"threshold_uncertainty_score":0.17653668},"labels":[],"label_agreement":null},{"id":"W4405092466","doi":"10.1016/s2665-9913(24)00335-7","title":"The inclusion of Indigenous voices in health research","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Cultural Competency in Health Care","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Indigenous; Inclusion (mineral); Sociology; Political science; Gender studies; Biology","score_opus":0.14292252278391018,"score_gpt":0.4746632223534727,"score_spread":0.33174069956956254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092466","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033357095,0.0448898,0.006773356,0.8432397,0.011493443,0.00012638164,0.00005241519,0.000052788208,0.06001505],"genre_scores_gemma":[0.7268285,0.032750722,0.010575109,0.20892511,0.013895726,0.0005178222,0.000054728902,0.00013767337,0.0063145473],"study_design_codex":"qualitative","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.723382,0.22514987,0.009042601,0.006077858,0.026835449,0.00951233],"domain_scores_gemma":[0.4071505,0.5143606,0.012462783,0.026723918,0.019858038,0.019444248],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29904014,0.0006793494,0.0019059613,0.0049310713,0.015962776,0.017937452,0.004563628,0.015661128,0.005559249],"category_scores_gemma":[0.32808942,0.0012223364,0.0010042198,0.0027251719,0.076109976,0.025781207,0.032429874,0.021523535,0.00060117664],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016947354,0.00018693293,0.008869648,0.005063673,0.00039338676,0.001227066,0.44103622,0.00027798233,0.0014020478,0.33487228,0.03679524,0.16970609],"study_design_scores_gemma":[0.0001880797,0.00026519748,0.009450214,0.016303102,0.00028957214,0.0014690569,0.19350435,0.00066905865,0.001030149,0.519311,0.2573101,0.00021013687],"about_ca_topic_score_codex":0.013675282,"about_ca_topic_score_gemma":0.024826871,"teacher_disagreement_score":0.70095986,"about_ca_system_score_codex":0.007478828,"about_ca_system_score_gemma":0.04049469,"threshold_uncertainty_score":0.8644083},"labels":[],"label_agreement":null},{"id":"W4405625082","doi":"10.1016/s2665-9913(24)00275-3","title":"Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Cancer Institute; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Marcus Foundation","keywords":"Juvenile; Medicine; Stem cell; Refractory (planetary science); Transplantation; Lung transplantation; Retrospective cohort study; Hematopoietic stem cell transplantation; Arthritis; Haematopoiesis; Disease; Cohort; Lung; Juvenile rheumatoid arthritis; Immunology; Internal medicine; Biology","score_opus":0.01437390759259195,"score_gpt":0.29206521976541444,"score_spread":0.2776913121728225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405625082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916375,0.00019688708,0.000048148042,0.000026559916,0.0000048062593,0.000006276213,0.00041023683,0.0000020190107,0.0001413744],"genre_scores_gemma":[0.9988186,0.00020580797,0.00005921083,0.000029688892,0.0000104962,0.000008968436,0.000796637,0.0000037942716,0.00006680778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991387,0.00016498605,0.000101431244,0.00027869674,0.000120140416,0.00019591494],"domain_scores_gemma":[0.9978871,0.0002617993,0.0010205691,0.0002655087,0.00014309263,0.00042197396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090483244,0.0006038665,0.00059598533,0.00082944817,0.0007625217,0.0012781731,0.0007349156,0.0006289066,0.0012845747],"category_scores_gemma":[0.0022176397,0.00053467706,0.00091932685,0.0017796254,0.0007952069,0.0009763862,0.00121407,0.0011162801,0.00025492717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027996788,0.000060723265,0.99792993,0.000013520743,0.00015633689,0.00032699673,0.00013481158,0.000034156838,0.00028991475,0.000030276378,0.00012284101,0.0006205006],"study_design_scores_gemma":[0.000042038704,0.00021905497,0.9971523,0.000012227486,0.00012788043,0.0014075952,0.00062465115,0.00008247979,0.000071073475,0.000025420042,0.00022533446,0.000009873274],"about_ca_topic_score_codex":0.007012772,"about_ca_topic_score_gemma":0.0067545413,"teacher_disagreement_score":0.007012772,"about_ca_system_score_codex":0.0006932747,"about_ca_system_score_gemma":0.0006539561,"threshold_uncertainty_score":0.013943911},"labels":[],"label_agreement":null},{"id":"W4407681760","doi":"10.1016/s2665-9913(24)00312-6","title":"The effect of ixekizumab treatment on MRI sacroiliac joint structural lesions in patients with radiographic axial spondyloarthritis: post-hoc analysis of a 52-week, randomised, placebo-controlled trial with an active reference arm","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Sacroiliac joint; Post-hoc analysis; Placebo; Axial spondyloarthritis; Radiography; Physical therapy; Randomized controlled trial; Spondylarthritis; Post hoc; Radiology; Magnetic resonance imaging; Surgery; Sacroiliitis; Internal medicine; Alternative medicine; Arthritis; Pathology; Ankylosing spondylitis; Secukinumab","score_opus":0.010089251530141386,"score_gpt":0.26351940686805264,"score_spread":0.25343015533791124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407681760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969287,0.005858534,0.0006392396,0.0004176304,0.0009487617,0.0007746474,0.00060821767,0.000081847946,0.0009783173],"genre_scores_gemma":[0.99455535,0.0012153756,0.00066928304,0.00027987396,0.00045083076,0.0005724339,0.00047481316,0.000028375573,0.0017536728],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99691415,0.0017523228,0.00023902068,0.0005507958,0.0001451398,0.00039865338],"domain_scores_gemma":[0.9962541,0.0020458351,0.00057684164,0.00037965152,0.00023925501,0.0005042545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004438352,0.003286569,0.008928148,0.0005490991,0.0005818121,0.0020239556,0.0015172217,0.0026435633,0.005691069],"category_scores_gemma":[0.004860588,0.0015416523,0.006327768,0.0004943605,0.0021366328,0.0022007287,0.00081929594,0.0051475316,0.0009768128],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99432397,0.00063657144,0.00019643069,0.00024335312,0.0017184142,0.000012624348,0.000018354242,0.0001554713,0.0007139975,0.000016385866,0.00008604474,0.0018783865],"study_design_scores_gemma":[0.9131041,0.07789109,0.0035854727,0.000034751378,0.0038477734,0.000024034414,0.000046074245,0.0005454419,0.000565203,0.00008969454,0.00023108281,0.00003528332],"about_ca_topic_score_codex":0.0013059169,"about_ca_topic_score_gemma":0.0021024875,"teacher_disagreement_score":0.008928148,"about_ca_system_score_codex":0.0010297892,"about_ca_system_score_gemma":0.00093274,"threshold_uncertainty_score":0.023472548},"labels":[],"label_agreement":null},{"id":"W4409792015","doi":"10.1016/s2665-9913(25)00078-5","title":"A cold case of joint injury","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Joint (building); Cold injury; Structural engineering; Engineering; Biology","score_opus":0.03345665878384927,"score_gpt":0.3276959299114179,"score_spread":0.2942392711275686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409792015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5947924,0.06848854,0.005839604,0.17319325,0.022997264,0.0005845677,0.0010221566,0.0005568765,0.13252538],"genre_scores_gemma":[0.9331167,0.006748395,0.0013827845,0.029900292,0.021687066,0.00006199852,0.00020117352,0.00009053335,0.006810962],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99793434,0.00038825884,0.00021397894,0.0003276528,0.00034122623,0.00079451816],"domain_scores_gemma":[0.99470216,0.0019910913,0.0006403088,0.00067616,0.0004490249,0.001541227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009927957,0.0021319238,0.0019290156,0.004663615,0.006912239,0.0034491513,0.0028597699,0.021522239,0.005813929],"category_scores_gemma":[0.012633345,0.002065653,0.0029750199,0.0027264098,0.0042576646,0.0040627723,0.002913321,0.015410003,0.0023530829],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008539253,0.00003355997,0.0016415705,0.00004514459,0.00001710651,0.9946622,0.00020568544,0.000041504194,0.0001646345,0.00045324565,0.0018345136,0.0008153895],"study_design_scores_gemma":[0.00003537706,0.0001221853,0.0032933298,0.00008946705,0.000025057185,0.99159735,0.00045166444,0.0001485217,0.0001228471,0.00076116825,0.0033279187,0.000025198284],"about_ca_topic_score_codex":0.004997718,"about_ca_topic_score_gemma":0.004992888,"teacher_disagreement_score":0.021522239,"about_ca_system_score_codex":0.0032298446,"about_ca_system_score_gemma":0.0014345332,"threshold_uncertainty_score":0.023434222},"labels":[],"label_agreement":null},{"id":"W4410353027","doi":"10.1016/s2665-9913(25)00068-2","title":"Why is progressive ILD in systemic sclerosis so difficult to predict?","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Health and Medical Research Council","keywords":"Progressive systemic sclerosis; Medicine; Dermatology; RAYNAUD DISEASE","score_opus":0.023198439727270537,"score_gpt":0.28153447912924656,"score_spread":0.258336039401976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410353027","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.123831436,0.24799782,0.023676097,0.5543377,0.027350277,0.00019137334,0.0013731827,0.0006612365,0.020580942],"genre_scores_gemma":[0.7513943,0.078213125,0.014158138,0.07967103,0.07331427,0.00009743432,0.0010621031,0.0002206927,0.0018688123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99104893,0.0030247166,0.0016651076,0.0013603906,0.0022790167,0.0006219145],"domain_scores_gemma":[0.9093381,0.060549494,0.0068500554,0.0031998164,0.016371096,0.0036913848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02029525,0.0009656929,0.0040048137,0.0024911133,0.0013509677,0.0058478005,0.0024475104,0.004477753,0.0021178953],"category_scores_gemma":[0.11614589,0.0008789221,0.0010669505,0.001307685,0.0034724427,0.0123577425,0.0018904589,0.0119947875,0.0023914147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011557845,0.0005080623,0.3561978,0.0033185068,0.0013806338,0.0056477273,0.0026487233,0.0026012107,0.0023850505,0.011365521,0.17534785,0.43744308],"study_design_scores_gemma":[0.0007564206,0.001991575,0.43462846,0.016957236,0.0018638538,0.039786074,0.018355832,0.020058703,0.003100295,0.30361813,0.1577515,0.0011319516],"about_ca_topic_score_codex":0.004253753,"about_ca_topic_score_gemma":0.004471663,"teacher_disagreement_score":0.02029525,"about_ca_system_score_codex":0.0010926531,"about_ca_system_score_gemma":0.0019221964,"threshold_uncertainty_score":0.107332826},"labels":[],"label_agreement":null},{"id":"W4410579087","doi":"10.1016/s2665-9913(25)00092-x","title":"Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University Health Network; CReATe Fertility Centre; Toronto Rehabilitation Institute; Sinai Health System; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Temerty Faculty of Medicine, University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Autoantibody; Protein subunit; Medicine; Fetus; Potassium; Internal medicine; Sodium; Endocrinology; Pregnancy; Immunology; Antibody; Chemistry; Biology; Biochemistry; Genetics","score_opus":0.021350518186305983,"score_gpt":0.30965785469107204,"score_spread":0.28830733650476603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410579087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811625,0.0006506719,0.00033106047,0.000058054484,0.000019313651,0.00003115468,0.00016498218,0.000011428466,0.00061718846],"genre_scores_gemma":[0.9990089,0.00029565117,0.00016193288,0.000038795864,0.000034197714,0.000020717309,0.00012368483,0.000008022756,0.0003081057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979044,0.00054123305,0.00020830167,0.00087086123,0.00024704376,0.00022807035],"domain_scores_gemma":[0.9968702,0.0012025998,0.0005815692,0.0006248807,0.00025812344,0.00046261624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015142015,0.0014015196,0.0011705495,0.0018528724,0.0018893922,0.001349183,0.0012589145,0.0020533898,0.004828952],"category_scores_gemma":[0.004976144,0.0015955734,0.0010326944,0.0017050665,0.0013182717,0.0008201611,0.0008112724,0.0011918395,0.0006545768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002767797,0.0014907755,0.9689956,0.00012396595,0.0012329473,0.013733484,0.001900784,0.00012550475,0.004217212,0.00044717742,0.0005505488,0.0044142446],"study_design_scores_gemma":[0.00045429516,0.0016760613,0.9695935,0.000049372073,0.0008495668,0.024222318,0.0009873495,0.00067607337,0.00044886334,0.00020479618,0.0007829152,0.000054818505],"about_ca_topic_score_codex":0.00998522,"about_ca_topic_score_gemma":0.00521094,"teacher_disagreement_score":0.00998522,"about_ca_system_score_codex":0.00074822764,"about_ca_system_score_gemma":0.00042651757,"threshold_uncertainty_score":0.019854188},"labels":[],"label_agreement":null},{"id":"W4410632835","doi":"10.1016/s2665-9913(25)00063-3","title":"ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations","year":2025,"lang":"en","type":"review","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; Dalhousie University; Toronto Western Hospital; University of Calgary; McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; European Commission","keywords":"Medicine; Systemic lupus; Intensive care medicine; Systemic lupus erythematosus; Systemic therapy; Dermatology; Pathology; Internal medicine; Disease","score_opus":0.10202908496049236,"score_gpt":0.3744690312559447,"score_spread":0.2724399462954524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410632835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008901561,0.9915705,0.00029089945,0.0033433726,0.0019896722,0.000039153998,0.00015919344,0.000023540271,0.0024946802],"genre_scores_gemma":[0.0009243951,0.99185103,0.00083259295,0.003238398,0.0012272352,0.00006171936,0.00038598003,0.000011564728,0.0014670807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982967,0.00043365595,0.0003935396,0.00016175018,0.00054101116,0.00017335199],"domain_scores_gemma":[0.9962561,0.0013792857,0.0007012535,0.000093823175,0.0012456496,0.00032375156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044737244,0.001183879,0.0034904976,0.0047549834,0.00048095788,0.0021965716,0.0027019586,0.0034436272,0.008706659],"category_scores_gemma":[0.0063775396,0.00043925695,0.0026996287,0.0026467144,0.00059449463,0.0014189929,0.0017465632,0.0032965168,0.0040055173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026726714,0.00005636603,0.0002432349,0.042465225,0.00043821256,0.00022396719,0.00006915165,0.00037591203,0.0007625698,0.0027873737,0.17005621,0.7822545],"study_design_scores_gemma":[0.00019613259,0.00010434101,0.0011867956,0.07013194,0.0011299462,0.00071008987,0.00006468661,0.000120087185,0.00026643777,0.001740706,0.9243125,0.000036304067],"about_ca_topic_score_codex":0.0048143244,"about_ca_topic_score_gemma":0.0066888016,"teacher_disagreement_score":0.008706659,"about_ca_system_score_codex":0.0020927368,"about_ca_system_score_gemma":0.0071490337,"threshold_uncertainty_score":0.029126704},"labels":[],"label_agreement":null},{"id":"W4410943761","doi":"10.1016/s2665-9913(25)00067-0","title":"Autoimmune disease in pregnancy: strengthening research and care","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario","funders":"","keywords":"Pregnancy; Disease; Autoimmune disease; Medicine; Intensive care medicine; Immunology; Biology; Internal medicine; Genetics","score_opus":0.02845163350667324,"score_gpt":0.3087360608032034,"score_spread":0.2802844272965302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410943761","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006411696,0.24601239,0.0009915285,0.72274584,0.025704838,0.000040362505,0.00014014331,0.00014701132,0.0035767523],"genre_scores_gemma":[0.046265673,0.5133236,0.008237383,0.2932472,0.13510795,0.00030447307,0.0005568825,0.0001106876,0.0028461597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9650222,0.017260872,0.004391522,0.0024559565,0.006381771,0.004487594],"domain_scores_gemma":[0.79486006,0.09842351,0.01516844,0.009065811,0.035370357,0.04711191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05818147,0.0029476548,0.006382128,0.0052378904,0.004180828,0.014707323,0.006132553,0.029287968,0.015858462],"category_scores_gemma":[0.124700256,0.001683982,0.0028410587,0.0033851904,0.010061982,0.01843787,0.018753953,0.031864423,0.0044438145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049098936,0.0004815637,0.0062736995,0.011105433,0.0006844025,0.0006720832,0.0013481557,0.0007986842,0.0007346623,0.023851141,0.6572158,0.29634336],"study_design_scores_gemma":[0.0014114178,0.00067154964,0.012505012,0.045957744,0.000970477,0.0013767673,0.006309621,0.0010690499,0.00041082982,0.08495284,0.84394115,0.00042359717],"about_ca_topic_score_codex":0.015058265,"about_ca_topic_score_gemma":0.016593488,"teacher_disagreement_score":0.05818147,"about_ca_system_score_codex":0.011503854,"about_ca_system_score_gemma":0.05357623,"threshold_uncertainty_score":0.3076967},"labels":[],"label_agreement":null},{"id":"W4413973580","doi":"10.1016/s2665-9913(25)00189-4","title":"Biomarkers for juvenile idiopathic arthritis treatment response—have we identified them?","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; BC Children's Hospital","funders":"","keywords":"Juvenile; Arthritis; Medicine; Internal medicine; Biology; Genetics","score_opus":0.04630402490178099,"score_gpt":0.336213690122051,"score_spread":0.28990966522027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413973580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03664914,0.86690986,0.002640574,0.07876792,0.009126372,0.00007701562,0.0014350789,0.0001751164,0.0042190417],"genre_scores_gemma":[0.56207263,0.29108012,0.016640587,0.08117854,0.041235916,0.00044535933,0.0034333603,0.00015337842,0.0037600875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9918134,0.0029677062,0.0016783731,0.0010794433,0.001740649,0.0007205057],"domain_scores_gemma":[0.9607216,0.019934747,0.008546692,0.0018264023,0.00718176,0.0017888241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015531709,0.001874363,0.0062603108,0.0028320854,0.000819565,0.008547477,0.0020785609,0.004440373,0.0050739935],"category_scores_gemma":[0.03910023,0.0010746062,0.0027860883,0.003018483,0.002367108,0.0072542736,0.00152705,0.0071146786,0.0018098104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039761006,0.00089021743,0.37443402,0.004644214,0.006364922,0.0005594293,0.00039823848,0.0012045709,0.0021257722,0.008839815,0.073788725,0.522774],"study_design_scores_gemma":[0.003040088,0.0038244089,0.60766697,0.020650424,0.012852136,0.003088662,0.003180622,0.008345561,0.0027508566,0.061070375,0.27260837,0.00092155504],"about_ca_topic_score_codex":0.0028887952,"about_ca_topic_score_gemma":0.003915102,"teacher_disagreement_score":0.015531709,"about_ca_system_score_codex":0.0021554888,"about_ca_system_score_gemma":0.003177689,"threshold_uncertainty_score":0.082140505},"labels":[],"label_agreement":null},{"id":"W4414002686","doi":"10.1016/s2665-9913(25)00255-3","title":"Challenges in the therapeutic management of psoriatic arthritis","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Psoriatic arthritis; Dermatology; Medicine; Psoriasis; Arthritis; Internal medicine","score_opus":0.055653406962852064,"score_gpt":0.3201426716906278,"score_spread":0.2644892647277758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414002686","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065039884,0.3872468,0.0007429559,0.6012612,0.00595927,0.000022551592,0.000039014107,0.00002904017,0.0040487917],"genre_scores_gemma":[0.037321873,0.6724114,0.008063105,0.20664695,0.0729003,0.0002873945,0.00013216435,0.000062497515,0.002174375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9608082,0.022819288,0.0056674755,0.0017080519,0.007117399,0.0018795246],"domain_scores_gemma":[0.899809,0.0654796,0.0067925667,0.0023427429,0.01563041,0.0099456245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07073294,0.00097211596,0.0044944524,0.0023586708,0.0033370182,0.012571706,0.0037152201,0.011652472,0.008474907],"category_scores_gemma":[0.07860559,0.00084611133,0.0019870487,0.0020135285,0.010483337,0.013098538,0.006013253,0.025390606,0.0037911604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007549883,0.0006419554,0.00148755,0.008877528,0.00041559277,0.0005756938,0.0014976737,0.00072657765,0.0005675617,0.050402068,0.22319089,0.710862],"study_design_scores_gemma":[0.0010358777,0.0011667403,0.0034353603,0.023286011,0.00045256582,0.002071394,0.006162131,0.0011630799,0.0002240201,0.103455715,0.857314,0.00023317387],"about_ca_topic_score_codex":0.0046139588,"about_ca_topic_score_gemma":0.01466544,"teacher_disagreement_score":0.07073294,"about_ca_system_score_codex":0.005204816,"about_ca_system_score_gemma":0.01869837,"threshold_uncertainty_score":0.374076},"labels":[],"label_agreement":null},{"id":"W4414300159","doi":"10.1016/s2665-9913(25)00105-5","title":"The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Research Canada; University of British Columbia","funders":"Faculty of Medicine and Health, University of Sydney; Holden Comprehensive Cancer Center, University of Iowa; Medical Research Council; Debre Tabor University; Adigrat University; Chettinad Academy of Research and Education; University of Portsmouth; Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu; University of Gondar; Western Sydney University; Universidade do Porto; University of Tabriz; Iran University of Medical Sciences; Chandigarh University; Shaqra University; United Arab Emirates University; Erasmus Universitair Medisch Centrum Rotterdam; International Osteoporosis Foundation; Turun Yliopisto; Universidade do Minho; Abdul Wali Khan University Mardan; University of South Carolina; University of Zanjan; Tanta University; Yarmouk University; Isfahan University of Medical Sciences; COMSATS Institute of Information Technology; University of California, San Diego; Arak University of Medical Sciences; Washington University in St. Louis; Zanjan University of Medical Sciences; University of New South Wales; University of Toronto; Universitas Padjadjaran; University of Washington; Curtin University of Technology; Università degli Studi di Milano; Bill and Melinda Gates Foundation; Tabriz University of Medical Sciences; Uniwersytet Łódzki; University of Canberra; University of Jordan; University of Leeds; University of Oxford; Monash University; University of Southampton; Tehran University of Medical Sciences and Health Services; National Cerebral and Cardiovascular Center; Arizona State University; Lunds Universitet; United International University","keywords":"Burden of disease; Risk factor; Disease burden; Disease; Risk assessment; Epidemiology","score_opus":0.033067164134259946,"score_gpt":0.358194440132207,"score_spread":0.3251272759979471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414300159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89952695,0.020776747,0.0027266447,0.0015341144,0.00021695564,0.0001778651,0.07278792,0.00012335781,0.002129383],"genre_scores_gemma":[0.9538535,0.0043139257,0.0013631139,0.00020918666,0.00011630328,0.00019539348,0.039366674,0.00003228061,0.0005496045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991365,0.000245038,0.000082145416,0.00017694387,0.00022970658,0.00012961835],"domain_scores_gemma":[0.9989519,0.00017639482,0.0003782943,0.000073669886,0.00027553443,0.00014413797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027664958,0.0009855644,0.000970196,0.0027349098,0.00039160662,0.0011608867,0.0008695894,0.00095683296,0.0018223729],"category_scores_gemma":[0.003176434,0.00048073372,0.0037165617,0.0049176617,0.0003409219,0.0007481976,0.0013857867,0.00130935,0.00047469113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063550065,0.000054033422,0.9852469,0.00024906697,0.0021066638,0.0001177004,0.0001000931,0.0020196864,0.000109710614,0.0002735755,0.0029684608,0.0061186966],"study_design_scores_gemma":[0.00006355836,0.0001043767,0.99143887,0.00008206439,0.0009156726,0.00017204526,0.00016973903,0.004258007,0.000054046373,0.00025622375,0.0024609398,0.0000244006],"about_ca_topic_score_codex":0.073938735,"about_ca_topic_score_gemma":0.042644788,"teacher_disagreement_score":0.073938735,"about_ca_system_score_codex":0.0013382107,"about_ca_system_score_gemma":0.001230663,"threshold_uncertainty_score":0.1470167},"labels":[],"label_agreement":null},{"id":"W4416377764","doi":"10.1016/s2665-9913(25)00257-7","title":"Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries","year":2025,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Antiphospholipid syndrome; Risk factor; Disease; Antibody; Case-control study; Systemic lupus erythematosus","score_opus":0.02040950275504672,"score_gpt":0.2844481605212552,"score_spread":0.2640386577662085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416377764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980508,0.00042758067,0.000070181326,0.00005467573,0.00001821163,0.000011694288,0.0009764526,0.000004061901,0.00038627294],"genre_scores_gemma":[0.9982457,0.00019778554,0.00008471951,0.000056376244,0.000018472238,0.000020177491,0.0010788915,0.0000031025065,0.0002948857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986494,0.0005550244,0.00014918805,0.0003026755,0.00015782317,0.00018588066],"domain_scores_gemma":[0.9980636,0.00033411258,0.00064537884,0.0002399867,0.0002559825,0.0004608617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014706784,0.0006764708,0.00071360695,0.0010044078,0.0008797177,0.0015523857,0.00072422647,0.0014402543,0.0010760727],"category_scores_gemma":[0.0029408517,0.0010872574,0.0013066939,0.0026253997,0.00062693737,0.0008801872,0.0008597465,0.0014085679,0.0003397791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010452436,0.00005540167,0.9989503,0.000009643778,0.00023355246,0.000047844474,0.00009611327,0.000032308173,0.00008104586,0.000011567305,0.00007045101,0.00030716383],"study_design_scores_gemma":[0.000015350237,0.00009857039,0.99939895,0.0000036210167,0.00006417732,0.000084038795,0.00019330793,0.000042173775,0.000013073727,0.000009099537,0.00007406276,0.0000035302073],"about_ca_topic_score_codex":0.021282148,"about_ca_topic_score_gemma":0.021283528,"teacher_disagreement_score":0.021282148,"about_ca_system_score_codex":0.00045484325,"about_ca_system_score_gemma":0.00047953802,"threshold_uncertainty_score":0.042316496},"labels":[],"label_agreement":null}]}